Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery
Open accessAbstract
Oxytocin (OT) and arginine-vasopressin (AVP) act in the brain to regulate social cognition/social behavior and in the periphery to influence a variety of physiological processes. Although the chemical structures of OT and AVP as well as their receptors are quite similar, OT and AVP can have distinct or even opposing actions. Here, we review the increasing body of evidence that exogenously administered and endogenously released OT and AVP can activate each other’s canonical receptors (i.e., cross-talk) and examine the possibility that receptor cross-talk following the synaptic and non-synaptic release of OT and AVP contributes to their distinct roles in the brain and periphery. Understanding the consequences of cross-talk between OT and AVP receptors will be important in identifying how these peptides control social cognition and behavior and for the development of drugs to treat a variety of psychiatric disorders.
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that oxytocin (OT) and arginine-vasopressin (AVP) can activate each other’s canonical receptors, especially at high concentrations, producing receptor cross-talk in the brain and periphery. It suggests that distinct or opposing effects of OT and AVP often depend more on which receptor is activated than on which peptide is present, with implications for intranasal OT/AVP studies and psychiatric drug development.
Key findings
- OT and AVP share seven of nine amino acid sequences, differing only at positions 3 and 8; their receptors are structurally similar, with about 25% sequence identity among human OTR, V1aR, V1bR, and V2R and 85% homology between V1aR and OTR.
- Receptor selectivity is limited: there can be around 10–100-fold differences in selectivity of OTRs and AVP receptors for OT and AVP; AVP has similar affinity for OTRs, V1aRs, and V1bRs, while OT may have higher affinity for OTRs than V1aRs or V1bRs.
- Cross-talk is supported in both periphery and brain: peripherally administered OT can act via V1aRs for analgesia, locomotor reduction, adjacent lying, and social huddling, while AVP can act via OTRs for uterine contractions and social investigation; centrally, OT can act via V1aRs for flank marking, and both OT and AVP can act via OTRs for social recognition and social reward.
- In Syrian hamsters, both OT and AVP induce flank marking dose-dependently, but AVP is around 100-fold more potent than OT; selective V1aR, not OTR, agonists/antagonists mediate this effect. Intranasal OT/AVP at commonly used 20–40 IU produces supraphysiological peripheral levels and likely activates OTRs, V1aRs, V1bRs, and V2Rs.
Methods
- Narrative review; no new experimental data, sample, or primary analysis are reported.
- The authors synthesize evidence from in vitro and in vivo receptor selectivity assays, behavioral pharmacology with selective OT/AVP receptor agonists and antagonists, genetic manipulations including knockouts, anatomical and electron microscopic studies, and microdialysis/peptide release studies across species.
- Main analysis is qualitative integration of these findings to assess when exogenous or endogenous OT and AVP may cross-activate each other’s receptors.
Limitations
- The paper states that much of the discussed data were collected in males despite major sex differences in OT and AVP systems, and that there is no “gold standard” for defining receptor selectivity.
- The paper states that selectivity estimates come from different assays, limited tissues, and only a few species, and that brain levels of peptide produced by intranasal administration are not well understood.
- The paper states that little is known about how frequently OT/AVP synapses contain the corresponding receptors, that OT/AVP receptors cannot currently be identified with immunohistochemistry, and that cross-talk following endogenously released peptides remains to be confirmed; evident from the text, this is a narrative rather than systematic review.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 136 cited sources checked · 0 supported · 0 flagged
- Premisecitation
Studies using recombinant expression systems for human, rat, and mouse OT and AVP receptors have shown that only the human OTR is selective for OT by a standard criterion.
“For example, studies employing recombinant expression systems to examine selectivity of human, rat, and mouse OT and AVP receptors have shown that only the human OTR is selective for OT using a standard criterion [34; 35] (Table 1).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [34] Manning M Stoev S Chini B Durroux B Mouillac B Guillon G Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents Neumann ID Landgraf R Advances in Vasopressin and Oxytocin: From genes to behavior Elsevier 2008 473 512 18655903 source
Not checked in the free run.
- cites [35] Manning M Misicka A Olma A Bankowski K Stoev S Chini B Durroux T Mouillac B Corbani M Guillon G Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics Journal of Neuroendocrinology 24 2012 609 628 22375852 PMC3490377 source
Not checked in the free run.
- Interpretationnone given
OT and AVP can activate each other's canonical receptors, a phenomenon termed cross-talk.
“Here, we review the increasing body of evidence that exogenously administered and endogenously released OT and AVP can activate each other’s canonical receptors (i.e., cross-talk)”
- Also stated in: § 1. Introduction · plain
“Recently, however, there has been increasing evidence that OT and AVP can act on each other’s canonical receptors in potentially important ways.”
Quote in the paperSubstantial claim - Also stated in: § 1. Introduction · plain
- Premisecitation
There can be differences of around 10-100 fold in the selectivity of OTRs and AVP receptors for OT and AVP.
“Nevertheless, it appears that there can be differences of around 10–100 fold in the selectivity of OTRs and AVP receptors for OT and AVP.”
- Also stated in: § 4. Receptor cross-talk in response to exogenously administered peptides · hedged
“Existing data suggest that there are 10–100 fold differences in the selectivity of OT and AVP for OTRs, V1aRs, and V1bRs”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [28] Chini B Mouillac B Ala Y Balestre MN Trumpp-Kallmeyer S Hoflack J Elands J Hibert M Manning M Jard S Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor EMBO J 14 1995 2176 2182 7774575 PMC398323 source
Not checked in the free run.
- cites [29] Hawtin SR Wesley VJ Parslow RA Patel S Wheatley M Critical role of a subdomain of the N-terminus of the V1a vasopressin receptor for binding agonists but not antagonists; functional rescue by the oxytocin receptor N-terminus Biochemistry 39 2000 13524 33 11063589 source
Not checked in the free run.
- cites [30] Kimura T Makino Y Saji F Takemura M Inoue T Kikuchi T Kubota Y Azuma C Nobunaga T Tokugawa Y Molecular characterization of a cloned human oxytocin receptor Eur J Endocrinol 131 1994 385 90 7921228 source
Not checked in the free run.
- cites [31] Lolait SJ O’Carroll AM Brownstein MJ Molecular biology of vasopressin receptors Ann N Y Acad Sci 771 1995 273 92 8597406 source
Not checked in the free run.
- cites [32] Thibonnier M Coles P Thibonnier A Shoham M The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists Annu Rev Pharmacol Toxicol 41 2001 175 202 11264455 source
Not checked in the free run.
- cites [33] Song Z McCann KE McNeill JK Larkin TE Huhman KL Albers HE Oxytocin induces social communication by activating arginine-vasopressin V1a receptors and not oxytocin receptors Psychoneuroendocrinology 50C 2014 14 19 PMC4252597 25173438 source
Not checked in the free run.
- Also stated in: § 4. Receptor cross-talk in response to exogenously administered peptides · hedged
- Interpretationreasoning
The overall lack of receptor selectivity is not surprising given the high degree of structural homology among these receptors, such as 85% between V1aR and OTR.
“This overall lack of receptor selectivity is not surprising when one considers that these receptors have a high degree of structural homology (e.g., 85% between V1aR and OTR) (Figure 4).”
Quote in the paperNot a substantial claim - Premisecitation
Despite similar chemical structures of OT, AVP, and their receptors, the two peptides can have distinct or even opposing roles in many behavioral and physiological functions.
“Although the chemical structures of OT and AVP as well as their receptors are quite similar, OT and AVP can have distinct or even opposing actions.”
- Also stated in: § 1. Introduction · boosted
“Although the chemical structures of OT and AVP as well as their receptors are quite similar, there is substantial evidence that these nonapeptides (i.e., nine amino acid peptides) can have distinct or even opposing roles in the regulation of many behavioral and physiological functions [3; 4; 5; 6; 7].”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [3] Neumann ID Landgraf R Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors Trends Neurosci 35 2012 649 659 22974560 source
Not checked in the free run.
- cites [4] Legros JJ Inhibitory effect of oxytocin on corticotrope function in humans: are vasopressin and oxytocin ying-yang neurohormones? Psychoneuroendocrinology 26 2001 649 655 11500247 source
Not checked in the free run.
- cites [5] Stoop R Neuromodulation by oxytocin and vasopressin Neuron 76 2012 142 159 23040812 source
Not checked in the free run.
- cites [6] Heinrichs M von Dawans B Domes G Oxytocin, vasopressin, and human social behavior Front Neuroendocrinol 30 2009 548 57 19505497 source
Not checked in the free run.
- cites [7] Carter CS Grippo AJ Pournajafi-Nazarloo H Ruscio MG Porges SW Oxytocin, vasopressin and sociality Prog Brain Res 170 2008 331 6 18655893 source
Not checked in the free run.
- Also stated in: § 1. Introduction · boosted
- Premisecitation
Selective V1aR but not OTR antagonists inhibit both OT- and AVP-induced analgesia in wild-type mice.
“In addition, selective V1aR but not OTR antagonists inhibit both OT- and AVP- induced analgesia in wild-type mice.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [40] Schorscher-Petcu A Sotocinal S Ciura S Dupre A Ritchie J Sorge RE Crawley JN Hu SB Nishimori K Young LJ Tribollet E Quirion R Mogil JS Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse J Neurosci 30 2010 8274 84 20554879 PMC2902996 source
Not checked in the free run.
- Premisecitation
Peripheral administration of OT or AVP induces analgesia in OTR but not in V1aR knock-out male and female mice.
“Peripheral administration of OT or AVP induces analgesia in OTR but not in V1aR knock-out male and female mice [40].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [40] Schorscher-Petcu A Sotocinal S Ciura S Dupre A Ritchie J Sorge RE Crawley JN Hu SB Nishimori K Young LJ Tribollet E Quirion R Mogil JS Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse J Neurosci 30 2010 8274 84 20554879 PMC2902996 source
Not checked in the free run.
- Premisecitation
AVP acts on V1aRs to stimulate flank marking.
“Structure-activity studies as well as the central injection of highly selective V1a agonists and antagonists indicates that AVP acts on V1aRs to stimulate flank marking [59; 60].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [59] Albers HE Pollock J Simmons WH Ferris CF A V1-like receptor mediates vasopressin-induced flank marking behavior in hamster hypothalamus J Neurosci 6 1986 2085 9 3016215 PMC6568576 source
Not checked in the free run.
- cites [60] Ferris CF Singer EA Meenan DM Albers HE Inhibition of vasopressin-stimulated flank marking behavior by V1-receptor antagonists Eur J Pharmacol 154 1988 153 9 2976377 source
Not checked in the free run.
- Premisecitation
Injection of AVP into several brain sites, including the anterior hypothalamus, lateral septum, and periaqueductal gray, induces robust bouts of flank marking in Syrian hamsters.
“Injection of AVP into several brain sites including the anterior hypothalamus (AH), the lateral septum (LS), and the periaqueductal gray (PAG), induce robust bouts of flank marking [55; 56; 57; 58].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [55] Hennessey AC Whitman DC Albers HE Microinjection of Arginine-Vasopressin into the Periaqueductal Gray Stimulates Flank Marking in Syrian-Hamsters (Mesocricetus-Auratus) Brain Research 569 1992 136 140 1611473 source
Not checked in the free run.
- cites [56] Ferris CF Albers HE Wesolowski SM Goldman BD Luman SE Vasopressin injected into the hypothalamus triggers a stereotypic behavior in golden hamsters Science 224 1984 521 523 6538700 source
Not checked in the free run.
- cites [57] Irvin RW Szot P Dorsa DM Potegal M Ferris CF Vasopressin in the septal area of the golden hamster controls scent marking and grooming Physiol Behav 48 1990 693 9 2082369 source
Not checked in the free run.
- cites [58] Huhman KL Babagbemi TO Albers HE Bicuculline Blocks Neuropeptide Y-Induced Phase Advances When Microinjected in the Suprachiasmatic Nucleus of Syrian-Hamsters Brain Research 675 1995 333 336 7796148 source
Not checked in the free run.
- Premisecitation
The ability of peripheral OT to reduce locomotor activity in male rats is reduced by a selective V1aR antagonist.
“The ability of peripheral administration of OT to reduce locomotor activity in male rats is reduced by a selective V1aR antagonist [43].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [43] Hicks C Ramos L Dampney B Baracz SJ McGregor IS Hunt GE Regional c-Fos expression induced by peripheral oxytocin administration is prevented by the vasopressin 1A receptor antagonist SR49059 Brain Res Bull 127 2016 208 218 27725169 source
Not checked in the free run.
- Premisecitation
Central administration of OT and AVP significantly influences the duration of social recognition in rats and mice.
“There is considerable evidence that central administration of OT and AVP significantly influences the duration of social recognition in rats and mice [61; 62].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [61] Gabor CS Phan A Clipperton-Allen AE Kavaliers M Choleris E Interplay of oxytocin, vasopressin, and sex hormones in the regulation of social recognition Behav Neurosci 126 2012 97 109 22141469 source
Not checked in the free run.
- cites [62] Albers HE The regulation of social recognition, social communication and aggression: vasopressin in the social behavior neural network Horm Behav 61 2012 283 92 22079778 source
Not checked in the free run.
- Premisecitation
Flank gland odors are recognized for at least 24 hrs after a brief 3 min exposure.
“Indeed, flank gland odors were found to be recognized for at least 24 hrs after a brief 3 min exposure.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [65] Song Z Larkin TE Malley MO Albers HE Oxytocin (OT) and arginine-vasopressin (AVP) act on OT receptors and not AVP V1a receptors to enhance social recognition in adult Syrian hamsters (Mesocricetus auratus) Horm Behav 81 2016 20 7 26975586 source
Not checked in the free run.
- Interpretationreasoning
Peripherally administered OT and AVP can act through V1aRs to alter physiology and behavior.
“Taken together, these data suggest that peripherally administered OT and AVP can act through V1aRs to alter physiology and behavior.”
Quote in the paperSubstantial claim - Premisecitation
Central administration of OT or AVP induces scratching behavior in wild-type and OTR knock-out male and female mice but not in V1aR knock-out mice.
“Central administration of OT or AVP induces scratching behavior in wild-type and OTR knock-out male and female mice but not in V1aR knock-out mice [40].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [40] Schorscher-Petcu A Sotocinal S Ciura S Dupre A Ritchie J Sorge RE Crawley JN Hu SB Nishimori K Young LJ Tribollet E Quirion R Mogil JS Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse J Neurosci 30 2010 8274 84 20554879 PMC2902996 source
Not checked in the free run.
- Premisecitation
In the pituitary gland, OT induces release of adrenocorticotropin via both OTRs and V1bRs in male mice and female rats.
“In the pituitary gland OT induces release of adrenocorticotropin via both OTRs and V1bRs in male mice and female rats [50; 51].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [50] Schlosser SF Almeida OF Patchev VK Yassouridis A Elands J Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type Endocrinology 135 1994 2058 63 7956927 source
Not checked in the free run.
- cites [51] Nakamura K Fujiwara Y Mizutani R Sanbe A Miyauchi N Hiroyama M Yamauchi J Yamashita T Nakamura S Mori T Tsujimoto G Tanoue A Effects of vasopressin V1b receptor deficiency on adrenocorticotropin release from anterior pituitary cells in response to oxytocin stimulation Endocrinology 149 2008 4883 91 18583426 source
Not checked in the free run.
- Premisecitation
Uterine contractions induced by OT or AVP are largely mediated by OTRs.
“Uterine contractions induced by OT or AVP are largely mediated by OTRs [46; 47; 48].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [46] Bossmar T Akerlund M Fantoni G Szamatowicz J Melin P Maggi M Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban Am J Obstet Gynecol 171 1994 1634 42 7802081 source
Not checked in the free run.
- cites [47] Akerlund M Bossmar T Brouard R Kostrzewska A Laudanski T Lemancewicz A Serradeil-Le Gal C Steinwall M Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women Br J Obstet Gynaecol 106 1999 1047 53 10519430 source
Not checked in the free run.
- cites [48] Kawamata M Mitsui-Saito M Kimura T Takayanagi Y Yanagisawa T Nishimori K Vasopressin-induced contraction of uterus is mediated solely by the oxytocin receptor in mice, but not in humans Eur J Pharmacol 472 2003 229 34 12871758 source
Not checked in the free run.
- Interpretationcitation
The analgesic effects of peripheral V1aR activation by OT and AVP may be mediated by V1aR modulation of ion channels in primary sensory neurons.
“These analgesic effects of peripheral activation of V1aRs by OT and AVP may be mediated by V1aR modulation of ion channels in primary sensory neurons [41; 42].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [41] Qiu F Qiu CY Cai H Liu TT Qu ZW Yang Z Li JD Zhou QY Hu WP Oxytocin inhibits the activity of acid-sensing ion channels through the vasopressin, V1A receptor in primary sensory neurons Br J Pharmacol 171 2014 3065 76 24641084 PMC4055206 source
Not checked in the free run.
- cites [42] Kubo A Shinoda M Katagiri A Takeda M Suzuki T Asaka J Yeomans DC Iwata K Oxytocin alleviates orofacial mechanical hypersensitivity associated with infraorbital nerve injury through vasopressin-1A receptors of the rat trigeminal ganglia Pain 158 2017 649 659 28072605 source
Not checked in the free run.
- Premisecitation
A highly selective OTR but not V1aR agonist increased the duration of social recognition in a manner that mimicked the effects of OT and AVP.
“ICV injection of an OTR but not a V1aR agonist increased the duration of social recognition in a manner that mimicked the effects of OT and AVP.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [65] Song Z Larkin TE Malley MO Albers HE Oxytocin (OT) and arginine-vasopressin (AVP) act on OT receptors and not AVP V1a receptors to enhance social recognition in adult Syrian hamsters (Mesocricetus auratus) Horm Behav 81 2016 20 7 26975586 source
Not checked in the free run.
- Premisecitation
ICV injection of OT or AVP enhances social recognition, increasing social memory of flank gland odors from 24 to 48 hrs.
“As with other tests of social recognition, ICV injection of OT or AVP enhances social recognition; it increased social memory of flank gland odors from 24 to 48 hrs.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [65] Song Z Larkin TE Malley MO Albers HE Oxytocin (OT) and arginine-vasopressin (AVP) act on OT receptors and not AVP V1a receptors to enhance social recognition in adult Syrian hamsters (Mesocricetus auratus) Horm Behav 81 2016 20 7 26975586 source
Not checked in the free run.
- Premisecitation
OT can act via V1aRs to influence a range of social behaviors.
“There are also studies that have found that OT can act via V1aRs to influence a range of social behaviors [53].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [53] Sala M Braida D Lentini D Busnelli M Bulgheroni E Capurro V Finardi A Donzelli A Pattini L Rubino T Parolaro D Nishimori K Parenti M Chini B Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism Biol Psychiatry 69 2011 875 882 21306704 source
Not checked in the free run.
- Premisecitation
ICV administration of OT induces flank marking in male hamsters.
“More recently, ICV administration of OT has also been shown to induce flank marking in male hamsters [33].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] Song Z McCann KE McNeill JK Larkin TE Huhman KL Albers HE Oxytocin induces social communication by activating arginine-vasopressin V1a receptors and not oxytocin receptors Psychoneuroendocrinology 50C 2014 14 19 PMC4252597 25173438 source
Not checked in the free run.
- Premisecitation
Social recognition is enhanced by optogenetically-induced OT release in the brain in female rats.
“For example, social recognition is enhanced by optogenetically-induced OT release in the brain in female rats [63]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] Oettl LL Ravi N Schneider M Scheller MF Schneider P Mitre M da Silva Gouveia M Froemke RC Chao MV Young WS Meyer-Lindenberg A Grinevich V Shusterman R Kelsch W Oxytocin Enhances Social Recognition by Modulating Cortical Control of Early Olfactory Processing Neuron 90 2016 609 21 27112498 PMC4860033 source
Not checked in the free run.
- Premisecitation
Both OT and AVP administered peripherally increase a form of social interaction in male rats called 'adjacent lying'.
“Both OT and AVP administered peripherally increase a form of social interaction in male rats referred to as “adjacent lying” in which rats maintain passive side-by-side contact during their first interaction [44].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Ramos L Hicks C Kevin R Caminer A Narlawar R Kassiou M McGregor IS Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor Neuropsychopharmacology 38 2013 2249 59 23676791 PMC3773675 source
Not checked in the free run.
- Premisecitation
Administration of AVP into the septum improves social recognition in male Brattleboro rats, a mutant rat strain that naturally lacks AVP.
“administration of AVP into the septum improves social recognition in male Brattleboro rats, a mutant rat strain that naturally lacks AVP [64].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [64] Engelmann M Landgraf R Microdialysis administration of vasopressin into the septum improves social recognition in Brattleboro rats Physiol Behav 55 1994 145 9 8140159 source
Not checked in the free run.
- Interpretationreasoning
Very high levels of OT and AVP would likely result in the activation of all OT/AVP receptors.
“As a result, very high levels of OT and AVP would likely result in the activation of all OT/AVP receptors.”
Quote in the paperSubstantial claim - Interpretationreasoning
OT can act on V1bRs to influence endocrine activity.
“There is also some evidence to suggest that OT can act on V1bRs to influence endocrine activity.”
Quote in the paperSubstantial claim - Premisecitation
The few studies that have compared the effects of intranasally administered OT and AVP in humans have reported that these peptides do not have opposing roles.
“The few studies that have compared the effects of intranasally administered OT and AVP in humans have reported that these peptides do not have opposing roles.”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [84] Rilling JK DeMarco AC Hackett PD Thompson R Ditzen B Patel R Pagnoni G Effects of intranasal oxytocin and vasopressin on cooperative behavior and associated brain activity in men Psychoneuroendocrinology 37 2012 447 461 21840129 PMC3251702 source
Not checked in the free run.
- cites [86] Chen X Hackett PD DeMarco AC Feng C Stair S Haroon E Ditzen B Pagnoni G Rilling JK Effects of oxytocin and vasopressin on the neural response to unreciprocated cooperation within brain regions involved in stress and anxiety in men and women Brain Imaging Behav 10 2016 581 93 26040978 PMC4670292 source
Not checked in the free run.
- cites [87] Patel N Grillon C Pavletic N Rosen D Pine DS Ernst M Oxytocin and vasopressin modulate risk-taking Physiol Behav 139 2015 254 60 25446228 PMC4274653 source
Not checked in the free run.
- cites [88] Rilling JK Demarco AC Hackett PD Chen X Gautam P Stair S Haroon E Thompson R Ditzen B Patel R Pagnoni G Sex differences in the neural and behavioral response to intranasal oxytocin and vasopressin during human social interaction Psychoneuroendocrinology 39 2014 237 48 24157401 PMC3842401 source
Not checked in the free run.
- cites [89] Feng C Hackett PD DeMarco AC Chen X Stair S Haroon E Ditzen B Pagnoni G Rilling JK Oxytocin and vasopressin effects on the neural response to social cooperation are modulated by sex in humans Brain Imaging Behav 9 2015 754 64 25416642 source
Not checked in the free run.
- cites [90] Li T Chen X Mascaro J Haroon E Rilling JK Intranasal oxytocin, but not vasopressin, augments neural responses to toddlers in human fathers Horm Behav 2017 PMC5565399 28161387 source
Not checked in the free run.
- Interpretationreasoning
High levels of peptide produced within the periphery by intranasal administration likely result in activation of peripheral OTRs, V1aRs, V1bRs, and V2Rs.
“The high levels of peptide produced within the periphery by intranasal administration likely results in activation of peripheral OTRs, V1aRs, V1bRs, and V2Rs.”
Quote in the paperSubstantial claim - Premisecitation
OTR knock-out mice display significant deficits in social recognition.
“Similarly, OTR knock-out mice also display significant deficits in social recognition [69; 70; 71; 72].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [69] Macbeth AH Lee HJ Edds J Young WS 3rd Oxytocin and the oxytocin receptor underlie intrastrain, but not interstrain, social recognition Genes Brain Behav 8 2009 558 67 19531157 PMC2746010 source
Not checked in the free run.
- cites [70] Takayanagi Y Yoshida M Bielsky IF Ross HE Kawamata M Onaka T Yanagisawa T Kimura T Matzuk MM Young LJ Nishimori K Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice Proc Natl Acad Sci U S A 102 2005 16096 101 16249339 PMC1276060 source
Not checked in the free run.
- cites [71] Choleris E Little SR Mong JA Puram SV Langer R Pfaff DW Microparticle-based delivery of oxytocin receptor antisense DNA in the medial amygdala blocks social recognition in female mice Proc Natl Acad Sci U S A 104 2007 4670 5 17360582 PMC1838659 source
Not checked in the free run.
- cites [72] Lee HJ Caldwell HK Macbeth AH Tolu SG Young WS 3rd A conditional knockout mouse line of the oxytocin receptor Endocrinology 149 2008 3256 63 18356275 PMC2453083 source
Not checked in the free run.
- Interpretationreasoning
Cross-talk between OT and AVP receptors may be more limited in humans when the peptides are given at more physiological levels because in humans OT appears to have a higher affinity for its receptors than for AVP receptors.
“Cross-talk between OT and AVP receptors may be more limited in humans when the peptides are given at more physiological levels because in humans, OT appears to have a higher affinity for its receptors than for AVP receptors.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The actions of exogenously administered OT and AVP in both the periphery and the brain cannot be assumed to be the sole result of activation of their canonical receptors.
“As a result, it is clear that the actions of exogenously administered OT and AVP in both the periphery and the brain cannot be assumed to be the sole result of activation of their canonical receptors.”
Quote in the paperSubstantial claim - Premisecitation
Both OT and AVP injected into the ventral tegmental area enhance social reward in male Syrian hamsters tested using the conditioned place preference apparatus.
“Both OT and AVP injected into the ventral tegmental area (VTA), a key element in the mesolimbic reward network, enhanced social reward in male Syrian hamsters tested using the conditioned place preference (CPP) apparatus.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] Song Z Borland JM Larkin TE O’Malley M Albers HE Activation of oxytocin receptors, but not arginine-vasopressin V1a receptors, in the ventral tegmental area of male Syrian hamsters is essential for the reward-like properties of social interactions Psychoneuroendocrinology 74 2016 164 172 27632574 PMC6417503 source
Not checked in the free run.
- Premisecitation
A highly selective OTR but not V1aR agonist mimicked the reward-enhancing effects of OT and AVP.
“A highly selective OTR but not a highly selective V1aR agonist mimicked the reward-enhancing effects of OT and AVP.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] Song Z Borland JM Larkin TE O’Malley M Albers HE Activation of oxytocin receptors, but not arginine-vasopressin V1a receptors, in the ventral tegmental area of male Syrian hamsters is essential for the reward-like properties of social interactions Psychoneuroendocrinology 74 2016 164 172 27632574 PMC6417503 source
Not checked in the free run.
- Premisecitation
Antagonism of V1aRs in several different CNS sites impairs social recognition.
“Antagonism of V1aRs in several different CNS sites impairs social recognition [73; 74]”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [73] Tobin VA Hashimoto H Wacker DW Takayanagi Y Langnaese K Caquineau C Noack J Landgraf R Onaka T Leng G Meddle SL Engelmann M Ludwig M An intrinsic vasopressin system in the olfactory bulb is involved in social recognition Nature 464 2010 413 7 20182426 PMC2842245 source
Not checked in the free run.
- cites [74] Veenema AH Bredewold R De Vries GJ Vasopressin regulates social recognition in juvenile and adult rats of both sexes, but in sex- and age-specific ways Horm Behav 61 2012 50 6 22033278 PMC3264802 source
Not checked in the free run.
- Premisecitation
An OTR, but not a V1aR antagonist injected into the VTA inhibits social reward.
“Importantly, these studies also showed that an OTR, but not a V1aR antagonist injected into the VTA inhibits social reward.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] Song Z Borland JM Larkin TE O’Malley M Albers HE Activation of oxytocin receptors, but not arginine-vasopressin V1a receptors, in the ventral tegmental area of male Syrian hamsters is essential for the reward-like properties of social interactions Psychoneuroendocrinology 74 2016 164 172 27632574 PMC6417503 source
Not checked in the free run.
- Premisecitation
Social recognition in OT knock-out male mice is severely impaired.
“For example, social recognition in OT knock-out male mice is severely impaired [68; 69].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [68] Ferguson JN Young LJ Hearn EF Matzuk MM Insel TR Winslow JT Social amnesia in mice lacking the oxytocin gene Nat Genet 25 2000 284 8 10888874 source
Not checked in the free run.
- cites [69] Macbeth AH Lee HJ Edds J Young WS 3rd Oxytocin and the oxytocin receptor underlie intrastrain, but not interstrain, social recognition Genes Brain Behav 8 2009 558 67 19531157 PMC2746010 source
Not checked in the free run.
- Premisecitation
A V1aR antagonist inhibits the ability of OT to increase social recognition in OTR knock-out mice.
“as discussed above, a V1aR antagonist inhibits the ability of OT to increase social recognition in OTR knock-out mice [53].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [53] Sala M Braida D Lentini D Busnelli M Bulgheroni E Capurro V Finardi A Donzelli A Pattini L Rubino T Parolaro D Nishimori K Parenti M Chini B Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism Biol Psychiatry 69 2011 875 882 21306704 source
Not checked in the free run.
- Interpretationcitation
OT and AVP act on OTRs in the VTA to regulate the expression of social reward.
“These data support the possibility that OT and AVP act on OTRs in the VTA, to regulate the expression of social reward.”
Quote in the paperSubstantial claim - Premisecitation
Peptides administered via the intranasal route produce significant alterations in cognition and neuronal activity whether they are acting peripherally and/or centrally.
“It is clear, however, that peptides administered via the intranasal route produce significant alterations in cognition and neuronal activity whether they are acting peripherally and/or centrally.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [84] Rilling JK DeMarco AC Hackett PD Thompson R Ditzen B Patel R Pagnoni G Effects of intranasal oxytocin and vasopressin on cooperative behavior and associated brain activity in men Psychoneuroendocrinology 37 2012 447 461 21840129 PMC3251702 source
Not checked in the free run.
- Premisecitation
Hamsters injected with OT or AVP had a larger increase in time spent in the chamber associated with social interaction after conditioning compared to those injected with saline.
“Hamsters injected with OT or AVP had a larger increase in the time spent in the chamber associated with social-interaction after conditioning compared to those injected with saline.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] Song Z Borland JM Larkin TE O’Malley M Albers HE Activation of oxytocin receptors, but not arginine-vasopressin V1a receptors, in the ventral tegmental area of male Syrian hamsters is essential for the reward-like properties of social interactions Psychoneuroendocrinology 74 2016 164 172 27632574 PMC6417503 source
Not checked in the free run.
- Interpretationreasoning
Cross-talk may also occur among all OT/AVP receptors, particularly when these peptides are administered at high concentrations.
“Crosstalk may also occur among all OT/AVP receptors particularly when these peptides are administered at high concentrations.”
Quote in the paperSubstantial claim - Interpretationreasoning
The data examining the hypothesis that OTRs and not V1aRs are essential for social recognition are not entirely consistent.
“As a result, the data examining the hypothesis that OTRs and not V1aRs are essential for social recognition are not entirely consistent.”
Quote in the paperNot a substantial claim - Interpretationreasoning
OT or AVP release from synaptic terminals or release from axons in passage could produce a focal activation of local receptors.
“OT or AVP release from synaptic terminals or release from axons in passage could therefore produce a focal activation of local receptors (Figure 6).”
Quote in the paperSubstantial claim - Interpretationreasoning
The further that non-synaptically released neuropeptides spread at high concentrations, the greater the potential for receptor cross-talk despite the anatomical segregation of OT and AVP receptors.
“The further that non-synaptically released neuropeptides spread at high concentrations the greater potential for receptor cross-talk despite the anatomical segregation of OT and AVP receptors.”
Quote in the paperSubstantial claim - Interpretationcitation
There is only a limited amount of evidence that endogenously released OT or AVP can produce functionally significant responses by acting on each other's receptors.
“There is only a limited amount of evidence that endogenously released OT or AVP can produce functionally significant responses by acting on each other’s receptors.”
Quote in the paperSubstantial claim - Interpretationreasoning
The opposite effects of OT and AVP are more likely the result of which receptor is activated rather than which peptide was responsible for the activation.
“OT and AVP receptors are imbedded in neural circuits that are frequently anatomically separate so it is likely that the opposite effects of these peptides are more the result of which receptor is activated rather than which peptide was responsible for the activation.”
Quote in the paperSubstantial claim - Interpretationreasoning
When OT and AVP activate each other's receptors, it is likely that they will produce similar effects.
“When they do it is likely that OT and AVP will produce similar effects.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Because non-synaptic release does not require a change in membrane voltage, synaptic release and non-synaptic release can occur independently of each other.
“Because non-synaptic release does not require a change in membrane voltage, synaptic release and non-synaptic release can occur independently of each other.”
Quote in the paperSubstantial claim - Interpretationreasoning
Substantial non-synaptic release of either OT or AVP could activate a large number of OT and AVP receptors indiscriminately, thereby overriding the 'wiring' diagrams of OT and AVP networks.
“Substantial non-synaptic release of either OT or AVP could activate a large number of OT and AVP receptors indiscriminately, thereby overriding the “wiring” diagrams of OT and AVP networks.”
Quote in the paperNot a substantial claim - Premisecitation
α-MSH acts on melanocortin 4 receptors to induce non-synaptic release of OT but not AVP from hypothalamic neurons.
“α-MSH acts on melanocortin 4 receptors to induce non-synaptic release of OT but not AVP from hypothalamic neurons [118; 119].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [118] Sabatier N Caquineau C Dayanithi G Bull P Douglas AJ Guan XM Jiang M Van der Ploeg L Leng G Alpha-melanocyte-stimulating hormone stimulates oxytocin release from the dendrites of hypothalamic neurons while inhibiting oxytocin release from their terminals in the neurohypophysis J Neurosci 23 2003 10351 8 14614094 PMC6741015 source
Not checked in the free run.
- cites [119] Sabatier N alpha-Melanocyte-stimulating hormone and oxytocin: a peptide signalling cascade in the hypothalamus J Neuroendocrinol 18 2006 703 10 16879169 source
Not checked in the free run.
- Interpretationreasoning
The simple notion that OT and AVP always have diametrically opposed actions is incorrect.
“Therefore, a simple notion that OT and AVP always have diametrically opposed actions is incorrect.”
Quote in the paperSubstantial claim - Interpretationcitation
Endogenously released OT can act on V1aRs to induce social behavior.
“These data provide support for the possibility that endogenously released OT can act on V1aRs to induce social behavior.”
Quote in the paperSubstantial claim - Interpretationreasoning
OT and AVP receptors within these networks could be activated in very different patterns as the result of different combinations of synaptic and non-synaptic release.
“Therefore, OT and AVP receptors within these networks could be activated in very different patterns as the result of different combinations of synaptic and non-synaptic release.”
Quote in the paperSubstantial claim - Premisecitation
Depolarizing stimuli can induce OT and AVP release in a calcium-dependent manner in brain regions where AVP and OT fibers terminate synaptically.
“In addition, depolarizing stimuli can induce OT and AVP release in a calcium-dependent manner in brain regions where AVP and OT fibers terminate synaptically [105; 106; 107].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [105] Buijs RM Van Heerikhuize JJ Vasopressin and oxytocin release in the brain--a synaptic event Brain Res 252 1982 71 6 7172022 source
Not checked in the free run.
- cites [106] Neumann I Ludwig M Engelmann M Pittman QJ Landgraf R Simultaneous microdialysis in blood and brain: oxytocin and vasopressin release in response to central and peripheral osmotic stimulation and suckling in the rat Neuroendocrinology 58 1993 637 45 8127393 source
Not checked in the free run.
- cites [107] Landgraf R Neumann I Schwarzberg H Central and peripheral release of vasopressin and oxytocin in the conscious rat after osmotic stimulation Brain Research 457 1988 219 225 3219551 source
Not checked in the free run.
- Interpretationreasoning
Non-synaptic release of OT and AVP has the potential to result in substantial cross-talk among OT and AVP receptors across many brain regions.
“In any case, non-synaptic release of OT and AVP has the potential to result in substantial cross-talk among OT and AVP receptors across many brain regions.”
Quote in the paperSubstantial claim - Interpretationreasoning
When isolated receptors occur, more global forms of neuropeptide release, such as non-synaptic release, would be required for their activation.
“Nevertheless, when isolated receptors do occur more global forms of neuropeptide release, such as non-synaptic release, would be required for their activation.”
Quote in the paperSubstantial claim - Interpretationreasoning
Different patterns of OT and AVP receptor activation across structures within these networks could contribute to the regulation of the complex behaviors and physiological processes under their control.
“Different patterns of OT and AVP receptor activation across structures within these networks could contribute to the regulation of the complex behaviors and physiological processes under their control (see [8] for a review).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Albers HE Species, sex and individual differences in the vasotocin/vasopressin system: relationship to neurochemical signaling in the social behavior neural network Front Neuroendocrinol 36 2015 49 71 25102443 PMC4317378 source
Not checked in the free run.
- Premiseown data
Based on receptor autoradiography, OT and AVP receptors appear to be anatomically segregated in many areas of the brain.
“Based on approaches with less anatomical resolution (i.e., receptor autoradiography) OT and AVP receptors appear to be anatomically segregated in many areas of the brain (e.g., Figure 3).”
Quote in the paperSubstantial claim - Premisecitation
Endogenous release of OT and AVP in the brain may be the result of neuropeptide release from synaptic and/or non-synaptic regions of neurons.
“The endogenous release of OT and AVP in the brain may be the result of neuropeptide release from synaptic and/or non-synaptic regions of neurons, although the relative roles of these forms of release in different populations of OT and AVP-containing cells are controversial [93; 94; 95; 96].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [93] Johnson ZV Young LJ Oxytocin and vasopressin neural networks: Implications for social behavioral diversity and translational neuroscience Neurosci Biobehav Rev 76 2017 87 98 28434591 PMC5407410 source
Not checked in the free run.
- cites [94] Ross HE Young LJ Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior Front Neuroendocrinol 30 2009 534 47 19481567 PMC2748133 source
Not checked in the free run.
- cites [95] Knobloch HS Grinevich V Evolution of oxytocin pathways in the brain of vertebrates Front Behav Neurosci 8 2014 31 24592219 PMC3924577 source
Not checked in the free run.
- cites [96] Chini B Verhage M Grinevich V The Action Radius of Oxytocin Release in the Mammalian CNS: From Single Vesicles to Behavior Trends Pharmacol Sci 2017 28899620 source
Not checked in the free run.
- Interpretationreasoning
Cross-talk is likely to occur when neuropeptides are released non-synaptically and spread more globally due to volume transmission.
“Cross-talk is likely to occur when neuropeptides are released non-synaptically and spread more globally due to volume transmission.”
Quote in the paperNot a substantial claim - Premisecitation
A more global form of OT and AVP release can occur when these neuropeptides are released from non-synaptic regions of neurons, such as dendrites.
“A more global form of OT and AVP release can occur when these neuropeptides are released from non-synaptic regions of neurons (e.g., dendrites) (Figure 6) [108; 109; 110].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [108] Leng G Ludwig M Neurotransmitters and peptides: whispered secrets and public announcements J Physiol 586 2008 5625 32 18845614 PMC2655398 source
Not checked in the free run.
- cites [109] Landgraf R Neumann ID Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication Front Neuroendocrinol 25 2004 150 176 15589267 source
Not checked in the free run.
- cites [110] Engelmann M Wotjak CT Ebner K Landgraf R Behavioural impact of intraseptally released vasopressin and oxytocin in rats Exp Physiol 85 Spec No 2000 125S 130S 10795914 source
Not checked in the free run.
- Interpretationcitation
The number of mismatches between the presence of neuropeptides and their receptors may be at least partially the result of a lack of sensitivity of the techniques used to localize neuropeptides.
“Although “isolated” receptors appear to be a common phenomenon in the brain [116], the number of mismatches between the presence of neuropeptides and their receptors may be at least partially the result of a lack of sensitivity of the techniques used to localize neuropeptides [98; 117].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [98] Knobloch HS Charlet A Hoffmann LC Eliava M Khrulev S Cetin AH Osten P Schwarz MK Seeburg PH Stoop R Grinevich V Evoked axonal oxytocin release in the central amygdala attenuates fear response Neuron 73 2012 553 566 22325206 source
Not checked in the free run.
- cites [117] Grinevich V Knobloch-Bollmann HS Eliava M Busnelli M Chini B Assembling the Puzzle: Pathways of Oxytocin Signaling in the Brain Biol Psychiatry 79 2016 155 64 26001309 source
Not checked in the free run.
- Premisecitation
Electron microscopic analysis has revealed dense core vesicles containing AVP- and OT-ir in terminals located in synaptic regions of brain areas such as the habenula, lateral septum, amygdala, supraoptic nuclei, ventromedial hypothalamus, and the nucleus of the solitary tract.
“For example, electron microscopic analysis has revealed dense core vesicles containing AVP- and OT-ir in terminals located in synaptic regions of brain areas such as the habenula, lateral septum, amygdala, supraoptic nuclei, ventromedial hypothalamus and the nucleus of the solitary tract [98; 99; 100; 101; 102; 103; 104].”
Quote in the paperNot a substantial claim0 of 7 sources checked- cites [98] Knobloch HS Charlet A Hoffmann LC Eliava M Khrulev S Cetin AH Osten P Schwarz MK Seeburg PH Stoop R Grinevich V Evoked axonal oxytocin release in the central amygdala attenuates fear response Neuron 73 2012 553 566 22325206 source
Not checked in the free run.
- cites [99] Theodosis DT Oxytocin-immunoreactive terminals synapse on oxytocin neurones in the supraoptic nucleus Nature 313 1985 682 4 3883189 source
Not checked in the free run.
- cites [100] Peters JH McDougall SJ Kellett DO Jordan D Llewellyn-Smith IJ Andresen MC Oxytocin enhances cranial visceral afferent synaptic transmission to the solitary tract nucleus J Neurosci 28 2008 11731 40 18987209 PMC2585803 source
Not checked in the free run.
- cites [101] Griffin GD Ferri-Kolwicz SL Reyes BA Van Bockstaele EJ Flanagan-Cato LM Ovarian hormone-induced reorganization of oxytocin-labeled dendrites and synapses lateral to the hypothalamic ventromedial nucleus in female rats J Comp Neurol 518 2010 4531 45 20886620 PMC4323080 source
Not checked in the free run.
- cites [102] Buijs RM Swaab DF Immuno-electron microscopical demonstration of vasopressin and oxytocin synapses in the limbic system of the rat Cell Tissue Res 204 1979 355 65 527026 source
Not checked in the free run.
- cites [103] Voorn P Buijs RM An immuno-electronmicroscopical study comparing vasopressin, oxytocin, substance P and enkephalin containing nerve terminals in the nucleus of the solitary tract of the rat Brain Res 270 1983 169 73 6191839 source
Not checked in the free run.
- cites [104] Buijs RM Immunocytochemical demonstration of vasopressin and oxytocin in the rat brain by light and electron microscopy J Histochem Cytochem 28 1980 357 60 6989899 source
Not checked in the free run.
- Premisecitation
Dysfunctions in the actions of OT and AVP have been linked to psychiatric disorders such as autism, anxiety, and schizophrenia.
“Dysfunctions in the actions of OT and AVP have been linked to psychiatric disorders such as autism, anxiety and schizophrenia.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [81] Caldwell HK Albers HE Oxytocin, Vasopressin, and the Motivational Forces that Drive Social Behaviors Curr Top Behav Neurosci 27 2016 51 103 26472550 source
Not checked in the free run.
- cites [82] Modi ME Young LJ The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies Horm Behav 61 2012 340 50 22206823 PMC3483080 source
Not checked in the free run.
- cites [83] Meyer-Lindenberg A Domes G Kirsch P Heinrichs M Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine Nat Rev Neurosci 12 2011 524 38 21852800 source
Not checked in the free run.
- May combine two claims. 38
- Classified as probably not a substantial claim. 3
May combine two claims.
PremisecitationIn mammals, OT is considered to have a single canonical receptor (OTR), while AVP is thought to have three receptors: V1aR, V1bR, and V2R.
“In mammals, OT is considered to have only one canonical receptor (i.e., OTR) while AVP is thought to have three: V1aR, V1bR and V2R [16; 17; 18].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [16] Caldwell HK Young WS III Oxytocin and Vasopressin: Genetics and behavioral implications Lim R Neuroactive Proteins and Peptides Springer New York 2006 573 607
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [17] Barberis C Tribollet E Vasopressin and oxytocin receptors in the central nervous system Crit Rev Neurobiol 10 1996 119 54 8853957 source
Not checked in the free run.
- cites [18] Hasunuma I Toyoda F Okada R Yamamoto K Kadono Y Kikuyama S Roles of arginine vasotocin receptors in the brain and pituitary of submammalian vertebrates Int Rev Cell Mol Biol 304 2013 191 225 23809437 source
Not checked in the free run.
May combine two claims.
PremisecitationOxytocin and arginine-vasopressin act in the brain to regulate social behaviors and in the periphery to coordinate physiological functions.
“Oxytocin (OT) and arginine-vasopressin (AVP) act in the brain to regulate social cognition/social behavior and in the periphery to influence a variety of physiological processes.”
- Also stated in: § 1. Introduction · plain
“Oxytocin (OT) and arginine-vasopressin (AVP) are important chemical signals that act in the brain to regulate a large number of adaptive social behaviors and in the periphery to coordinate a diverse group of physiological functions [1; 2].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [1] Caldwell HK Oxytocin and Vasopressin: Powerful Regulators of Social Behavior Neuroscientist 2017 1073858417708284 28492104 source
Not checked in the free run.
- cites [2] Leng G Ludwig M Intranasal Oxytocin: Myths and Delusions Biol Psychiatry 79 2016 243 50 26049207 source
Not checked in the free run.
- Also stated in: § 1. Introduction · plain
May combine two claims.
PremisecitationIn the mammalian brain, OTRs and V1aRs are robustly expressed in many regions, but their distributions often differ.
“In mammalian brain OTRs and V1aRs are robustly expressed in many regions but their distributions often differ [9; 21; 22] (Figure 3).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [9] Dumais KM Veenema AH Vasopressin and oxytocin receptor systems in the brain: Sex differences and sex-specific regulation of social behavior Front Neuroendocrinol 40 2016 1 23 25951955 PMC4633405 source
Not checked in the free run.
- cites [21] Veinante P Freund-Mercier MJ Distribution of oxytocin- and vasopressin-binding sites in the rat extended amygdala: a histoautoradiographic study J Comp Neurol 383 1997 305 325 9205043 source
Not checked in the free run.
- cites [22] Smith CJ Poehlmann ML Li S Ratnaseelan AM Bredewold R Veenema AH Age and sex differences in oxytocin and vasopressin V1a receptor binding densities in the rat brain: focus on the social decision-making network Brain Struct Funct 222 2017 981 1006 27389643 PMC5334374 source
Not checked in the free run.
May combine two claims.
PremisecitationThese effects of OT and AVP can be inhibited by selective V1aR antagonists but not by OTR antagonists.
“These effects of OT and AVP can be inhibited by selective V1aR but not OTR antagonists.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [37] Hicks C Ramos L Reekie T Misagh GH Narlawar R Kassiou M McGregor IS Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats Br J Pharmacol 171 2014 2868 87 24641248 PMC4243861 source
Not checked in the free run.
- cites [38] Loyens E Vermoesen K Schallier A Michotte Y Smolders I Proconvulsive effects of oxytocin in the generalized pentylenetetrazol mouse model are mediated by vasopressin 1a receptors Brain Res 1436 2012 43 50 22208648 source
Not checked in the free run.
- cites [39] Gupta J Russell R Wayman C Hurley D Jackson V Oxytocin-induced contractions within rat and rabbit ejaculatory tissues are mediated by vasopressin V1A receptors and not oxytocin receptors Br J Pharmacol 155 2008 118 26 18552879 PMC2527840 source
Not checked in the free run.
May combine two claims.
PremisecitationPeripherally administered OT and AVP produce similar effects in reducing heart rate and body temperature, inducing contractions in ejaculatory tissues, and promoting seizure susceptibility in male rats and rabbits.
“Peripherally administered OT and AVP produce similar effects in reducing heart rate and body temperature, inducing contractions in ejaculatory tissues, and in promoting seizure susceptibility in male rats and rabbits [37; 38; 39].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [37] Hicks C Ramos L Reekie T Misagh GH Narlawar R Kassiou M McGregor IS Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats Br J Pharmacol 171 2014 2868 87 24641248 PMC4243861 source
Not checked in the free run.
- cites [38] Loyens E Vermoesen K Schallier A Michotte Y Smolders I Proconvulsive effects of oxytocin in the generalized pentylenetetrazol mouse model are mediated by vasopressin 1a receptors Brain Res 1436 2012 43 50 22208648 source
Not checked in the free run.
- cites [39] Gupta J Russell R Wayman C Hurley D Jackson V Oxytocin-induced contractions within rat and rabbit ejaculatory tissues are mediated by vasopressin V1A receptors and not oxytocin receptors Br J Pharmacol 155 2008 118 26 18552879 PMC2527840 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationV1bRs appear to have a much more restricted distribution, although they are expressed prominently in the hippocampus and at lower levels in the hypothalamus and amygdala.
“V1bRs appear to have a much more restricted distribution, although they are expressed prominently in the hippocampus and at lower levels in the hypothalamus and amygdala [23; 24].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [23] Young WS Li J Wersinger SR Palkovits M The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy Neuroscience 143 2006 1031 1039 17027167 PMC1748954 source
Not checked in the free run.
- cites [24] Stevenson EL Caldwell HK The vasopressin 1b receptor and the neural regulation of social behavior Hormones and Behavior 61 2012 277 282 22178035 PMC3310934 source
Not checked in the free run.
May combine two claims.
PremisecitationAVP has similar affinity for OTRs, V1aRs, and V1bRs, whereas OT may have a higher affinity for OTRs than for V1aRs or V1bRs.
“AVP has a similar affinity for OTRs, V1aRs, and V1bRs while OT may have a higher affinity for OTRs than V1aRs or V1bRs [28; 29; 30; 31; 32; 33].”
- Also stated in: § 4. Receptor cross-talk in response to exogenously administered peptides · plain
“AVP has similar affinities for OT and AVP receptors while OT has a higher affinity for OT receptors than AVP receptors.”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [28] Chini B Mouillac B Ala Y Balestre MN Trumpp-Kallmeyer S Hoflack J Elands J Hibert M Manning M Jard S Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor EMBO J 14 1995 2176 2182 7774575 PMC398323 source
Not checked in the free run.
- cites [29] Hawtin SR Wesley VJ Parslow RA Patel S Wheatley M Critical role of a subdomain of the N-terminus of the V1a vasopressin receptor for binding agonists but not antagonists; functional rescue by the oxytocin receptor N-terminus Biochemistry 39 2000 13524 33 11063589 source
Not checked in the free run.
- cites [30] Kimura T Makino Y Saji F Takemura M Inoue T Kikuchi T Kubota Y Azuma C Nobunaga T Tokugawa Y Molecular characterization of a cloned human oxytocin receptor Eur J Endocrinol 131 1994 385 90 7921228 source
Not checked in the free run.
- cites [31] Lolait SJ O’Carroll AM Brownstein MJ Molecular biology of vasopressin receptors Ann N Y Acad Sci 771 1995 273 92 8597406 source
Not checked in the free run.
- cites [32] Thibonnier M Coles P Thibonnier A Shoham M The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists Annu Rev Pharmacol Toxicol 41 2001 175 202 11264455 source
Not checked in the free run.
- cites [33] Song Z McCann KE McNeill JK Larkin TE Huhman KL Albers HE Oxytocin induces social communication by activating arginine-vasopressin V1a receptors and not oxytocin receptors Psychoneuroendocrinology 50C 2014 14 19 PMC4252597 25173438 source
Not checked in the free run.
- Also stated in: § 4. Receptor cross-talk in response to exogenously administered peptides · plain
May combine two claims.
PremisecitationA highly selective OTR agonist failed to induce flank marking, and a highly selective OTR antagonist failed to inhibit the induction of flank marking by OT.
“A highly selective OTR agonist failed to induce flank marking and a highly selective OTR antagonist failed to inhibit the induction of flank marking by OT.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] Song Z McCann KE McNeill JK Larkin TE Huhman KL Albers HE Oxytocin induces social communication by activating arginine-vasopressin V1a receptors and not oxytocin receptors Psychoneuroendocrinology 50C 2014 14 19 PMC4252597 25173438 source
Not checked in the free run.
May combine two claims.
PremisecitationA selective OTR antagonist, but not a selective V1aR antagonist, inhibits OT- and AVP-induced increases in social investigation, suggesting that both peptides act through the OTR.
“Peripheral administration of a selective OTR antagonist, but not a selective V1aR antagonist, inhibits OT- and AVP-induced increases in social investigation suggesting that both peptides are acting through the OTR [49].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [49] Ramos L Hicks C Caminer A Couto K Narlawar R Kassiou M McGregor IS MDMA (‘Ecstasy’), oxytocin and vasopressin modulate social preference in rats: A role for handling and oxytocin receptors Pharmacol Biochem Behav 150–151 2016 115 123 27725273 source
Not checked in the free run.
May combine two claims.
PremisecitationIn OTR null mice, social exploration and social recognition are reduced, while aggression is increased compared to wild-type mice.
“In OTR null mice social exploration and social recognition are reduced, while aggression is increased when compared to wild-type mice.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [53] Sala M Braida D Lentini D Busnelli M Bulgheroni E Capurro V Finardi A Donzelli A Pattini L Rubino T Parolaro D Nishimori K Parenti M Chini B Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism Biol Psychiatry 69 2011 875 882 21306704 source
Not checked in the free run.
May combine two claims.
PremisecitationA highly selective OTR but not V1aR antagonist significantly reduced the duration of social recognition, suggesting that OT and AVP regulate social recognition by acting on OTRs.
“A highly selective OTR but not a highly selective V1aR antagonist significantly reduced the duration of social recognition suggesting that OT and AVP regulate social recognition by acting on OTRs.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [65] Song Z Larkin TE Malley MO Albers HE Oxytocin (OT) and arginine-vasopressin (AVP) act on OT receptors and not AVP V1a receptors to enhance social recognition in adult Syrian hamsters (Mesocricetus auratus) Horm Behav 81 2016 20 7 26975586 source
Not checked in the free run.
May combine two claims.
PremisecitationPeripheral administration of either OT or AVP increases social huddling in response to threatening stimuli (cat fur), and these effects are inhibited by a selective V1aR antagonist.
“Peripheral administration of either OT or AVP also increases social huddling in response to threatening stimuli (i.e., cat fur) and these effects are inhibited by a selective V1aR antagonist [45].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] Bowen MT McGregor IS Oxytocin and vasopressin modulate the social response to threat: a preclinical study Int J Neuropsychopharmacol 17 2014 1621 1633 24807123 source
Not checked in the free run.
May combine two claims.
PremisecitationIn female meadow voles housed in winter-like conditions, injection of OT into the lateral septum prevents the formation of partner preferences, an effect blocked by co-administration of OT with a V1aR but not an OTR antagonist.
“When housed in winter-like conditions female voles form partner preferences for other females. Injection of OT into the lateral septum prevents the formation of these partner preferences, an effect that is blocked by co-administration of OT with a V1aR but not an OTR antagonist.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [54] Anacker AM Christensen JD LaFlamme EM Grunberg DM Beery AK Septal oxytocin administration impairs peer affiliation via V1a receptors in female meadow voles Psychoneuroendocrinology 68 2016 156 62 26974500 PMC4851907 source
Not checked in the free run.
May combine two claims.
PremisecitationA selective V1aR antagonist, but not an OTR antagonist, inhibits adjacent lying following peripheral administration of OT or AVP.
“A selective V1aR, but not an OTR antagonist, inhibits adjacent lying following peripheral administration of OT or AVP.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Ramos L Hicks C Kevin R Caminer A Narlawar R Kassiou M McGregor IS Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor Neuropsychopharmacology 38 2013 2249 59 23676791 PMC3773675 source
Not checked in the free run.
May combine two claims.
PremisecitationA selective V1aR agonist induced flank marking, and a selective V1aR antagonist inhibited the ability of OT to induce flank marking.
“In contrast, not only did a selective V1aR agonist induce flank marking, a selective V1aR antagonist inhibited the ability of OT to induce flank marking.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] Song Z McCann KE McNeill JK Larkin TE Huhman KL Albers HE Oxytocin induces social communication by activating arginine-vasopressin V1a receptors and not oxytocin receptors Psychoneuroendocrinology 50C 2014 14 19 PMC4252597 25173438 source
Not checked in the free run.
May combine two claims.
PremisecitationBoth OT and AVP administered peripherally increase social investigation in male rats.
“Both OT and AVP administered peripherally also increase social investigation in male rats.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [49] Ramos L Hicks C Caminer A Couto K Narlawar R Kassiou M McGregor IS MDMA (‘Ecstasy’), oxytocin and vasopressin modulate social preference in rats: A role for handling and oxytocin receptors Pharmacol Biochem Behav 150–151 2016 115 123 27725273 source
Not checked in the free run.
May combine two claims.
PremisecitationBoth OT and AVP inhibit neuronal signaling in dorsal root ganglia, and these effects can be inhibited by a selective V1aR antagonist but not by an OTR antagonist.
“Although both OT and AVP inhibit neuronal signaling in dorsal root ganglia, these effects can be inhibited by a selective V1aR antagonist but not by an OTR antagonist.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [41] Qiu F Qiu CY Cai H Liu TT Qu ZW Yang Z Li JD Zhou QY Hu WP Oxytocin inhibits the activity of acid-sensing ion channels through the vasopressin, V1A receptor in primary sensory neurons Br J Pharmacol 171 2014 3065 76 24641084 PMC4055206 source
Not checked in the free run.
- cites [42] Kubo A Shinoda M Katagiri A Takeda M Suzuki T Asaka J Yeomans DC Iwata K Oxytocin alleviates orofacial mechanical hypersensitivity associated with infraorbital nerve injury through vasopressin-1A receptors of the rat trigeminal ganglia Pain 158 2017 649 659 28072605 source
Not checked in the free run.
May combine two claims.
PremisecitationICV injection of OT or AVP can restore wild-type levels of these behaviors, and the effects of OT and AVP are inhibited by a selective V1aR antagonist.
“While intracerebroventricular (ICV) injection of OT or AVP can restore wild-type levels of these behaviors, the effects of OT and AVP are inhibited by a selective V1aR antagonist.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [53] Sala M Braida D Lentini D Busnelli M Bulgheroni E Capurro V Finardi A Donzelli A Pattini L Rubino T Parolaro D Nishimori K Parenti M Chini B Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism Biol Psychiatry 69 2011 875 882 21306704 source
Not checked in the free run.
May combine two claims.
PremisecitationBoth OT and AVP induce flank marking in a dose-dependent manner, although AVP is around 100-fold more potent than OT.
“Both OT and AVP induce flank marking in a dose-dependent manner, although AVP is around 100-fold more potent than OT in inducing the behavior (Figure 5).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] Song Z McCann KE McNeill JK Larkin TE Huhman KL Albers HE Oxytocin induces social communication by activating arginine-vasopressin V1a receptors and not oxytocin receptors Psychoneuroendocrinology 50C 2014 14 19 PMC4252597 25173438 source
Not checked in the free run.
May combine two claims.
PremisecitationOT can act on V1bRs as well as OTRs, and AVP can act on OTRs as well as V1bRs, to induce glucagon secretion from pancreatic islet cells in male mice.
“There is also evidence to suggest that OT can act on V1bRs as well as OTRs and that AVP can act on OTRs as well as V1bRs to induce glucagon secretion from pancreatic islet cells in male mice [52].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Fujiwara Y Hiroyama M Sanbe A Yamauchi J Tsujimoto G Tanoue A Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice J Endocrinol 192 2007 361 9 17283236 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningExogenously administered OT can act on V1aRs in the periphery, and exogenously administered AVP can act on peripheral OTRs to influence physiological and behavioral endpoints.
“There is considerable evidence that exogenously administered OT can act on V1aRs in the periphery and several examples that exogenously administered AVP can act on peripheral OTRs to influence both physiological and behavioral endpoints.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIn the brain, OT can act on V1aRs and AVP can act on OTRs to influence several different behaviors.
“In the brain, there is strong support for the hypothesis that OT can act on V1aRs and that AVP can act on OTRs to influence several different behaviors.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationOT and AVP can have differential effects on neural activity (BOLD fMRI responses) and cognition, at least in some cases, although the effects of OT are more robust.
“These data have, however, found OT and AVP can have differential effects on neural activity (i.e., BOLD fMRI responses) and cognition, at least in some cases although the effects of OT are more robust [84; 86; 87; 88; 89; 90].”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [84] Rilling JK DeMarco AC Hackett PD Thompson R Ditzen B Patel R Pagnoni G Effects of intranasal oxytocin and vasopressin on cooperative behavior and associated brain activity in men Psychoneuroendocrinology 37 2012 447 461 21840129 PMC3251702 source
Not checked in the free run.
- cites [86] Chen X Hackett PD DeMarco AC Feng C Stair S Haroon E Ditzen B Pagnoni G Rilling JK Effects of oxytocin and vasopressin on the neural response to unreciprocated cooperation within brain regions involved in stress and anxiety in men and women Brain Imaging Behav 10 2016 581 93 26040978 PMC4670292 source
Not checked in the free run.
- cites [87] Patel N Grillon C Pavletic N Rosen D Pine DS Ernst M Oxytocin and vasopressin modulate risk-taking Physiol Behav 139 2015 254 60 25446228 PMC4274653 source
Not checked in the free run.
- cites [88] Rilling JK Demarco AC Hackett PD Chen X Gautam P Stair S Haroon E Thompson R Ditzen B Patel R Pagnoni G Sex differences in the neural and behavioral response to intranasal oxytocin and vasopressin during human social interaction Psychoneuroendocrinology 39 2014 237 48 24157401 PMC3842401 source
Not checked in the free run.
- cites [89] Feng C Hackett PD DeMarco AC Chen X Stair S Haroon E Ditzen B Pagnoni G Rilling JK Oxytocin and vasopressin effects on the neural response to social cooperation are modulated by sex in humans Brain Imaging Behav 9 2015 754 64 25416642 source
Not checked in the free run.
- cites [90] Li T Chen X Mascaro J Haroon E Rilling JK Intranasal oxytocin, but not vasopressin, augments neural responses to toddlers in human fathers Horm Behav 2017 PMC5565399 28161387 source
Not checked in the free run.
May combine two claims.
PremisecitationCommonly used intranasal concentrations of OT and AVP (20 IU to 40 IU) produce high, supraphysiological levels of peptide in the periphery, and these concentrations are likely high enough to also produce biologically active levels in the brain.
“The commonly used intranasal concentrations of OT and AVP (i.e., 20 IU to 40 IU) produce high, supraphysiological levels of peptide in the periphery, and these concentrations are likely high enough to also produce biologically active levels in the brain [2].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Leng G Ludwig M Intranasal Oxytocin: Myths and Delusions Biol Psychiatry 79 2016 243 50 26049207 source
Not checked in the free run.
May combine two claims.
InterpretationcitationThere can be substantial cross-talk between OT and AVP and OTRs and V1aRs.
“Because OT and AVP as well as their canonical receptors display strikingly similar chemical structures, it is not surprising that there can be substantial cross-talk between these peptides and OTRs and V1aRs [79].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [79] Ragnauth AK Goodwillie A Brewer C Muglia LJ Pfaff DW Kow LM Vasopressin stimulates ventromedial hypothalamic neurons via oxytocin receptors in oxytocin gene knockout male and female mice Neuroendocrinology 80 2004 92 9 15528951 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningOT and AVP act exclusively on V1aRs to influence some behaviors, such as social communication, and exclusively on OTRs to influence other behaviors, such as social reward.
“There is also some evidence to suggest that OT and AVP act exclusively on V1aRs to influence some behaviors (e.g., social communication) and that OT and AVP act exclusively on OTRs to influence other behaviors (e.g., social reward).”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe potential for receptor cross-talk would likely be reduced by local synaptic release of neuropeptide and the anatomical segregation of OT and AVP receptors.
“The potential for receptor cross-talk would likely be reduced by local synaptic release of neuropeptide and the anatomical segregation of OT and AVP receptors.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningDifferences in the effects of OT and AVP could simply be the result of different doses and/or differences in the selectivity of OTRs for OT in humans.
“Thus, differences in the effects of OT and AVP could simply be the result of different doses and/or differences in the selectivity of OTRs for OT in humans.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIf the presence of both OT and AVP receptors in the same synaptic regions is rare, then the possibility of cross-talk following synaptic release of these neuropeptides would seem unlikely, with the exception of synaptic spillover.
“If the presence of both OT and AVP receptors in the same synaptic regions is rare then the possibility of cross-talk following synaptic release of these neuropeptides would seem unlikely, with the exception of when these neuropeptides spillover beyond synaptic regions (i.e., synaptic spillover).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationA major source of non-synaptically released OT and AVP is the magnocellular neurons in the hypothalamus, although there is also evidence that hypothalamic parvocellular neurons can release neuropeptides from dense core vesicles non-synaptically.
“A major source of non-synaptically released OT and AVP is the magnocellular neurons in the hypothalamus, although there is also evidence that hypothalamic parvocellular neurons can also release neuropeptides from dense core vesicles non-synaptically [111].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [111] Castel M Morris J Belenky M Non-synaptic and dendritic exocytosis from dense-cored vesicles in the suprachiasmatic nucleus Neuroreport 7 1996 543 7 8730825 source
Not checked in the free run.
May combine two claims.
PremisecitationNon-synaptic neuropeptide release is stimulated by Ca2+ coming from intracellular stores, as opposed to synaptic release that is mediated by the influx of extracellular Ca2+ through voltage-gated channels.
“Non-synaptic neuropeptide release is stimulated by Ca2+ coming from intracellular stores (e.g., endoplasmic reticulum) as opposed to synaptic release that is mediated by the influx of extracellular Ca2+ through voltage-gated channels [105].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [105] Buijs RM Van Heerikhuize JJ Vasopressin and oxytocin release in the brain--a synaptic event Brain Res 252 1982 71 6 7172022 source
Not checked in the free run.
May combine two claims.
Interpretationnone givenOT and AVP can activate each other's receptors, particularly when present at high levels, resulting in the potential for substantial cross-talk between the OT and AVP systems.
“Rather, OT and AVP can activate each other’s receptors, particularly when present at high levels, resulting in the potential for substantial cross-talk between the OT and AVP systems.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationICV or hypothalamic injection of α-MSH induces flank marking behavior in hamsters, and α-MSH-induced flank marking is blocked by central administration of a selective V1a antagonist.
“Studies in hamsters have found that ICV or hypothalamic injection of α-MSH induces flank marking behavior and that α-MSH-induced flank marking is blocked by central administration of a selective V1a antagonist [33].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] Song Z McCann KE McNeill JK Larkin TE Huhman KL Albers HE Oxytocin induces social communication by activating arginine-vasopressin V1a receptors and not oxytocin receptors Psychoneuroendocrinology 50C 2014 14 19 PMC4252597 25173438 source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
InterpretationreasoningIntranasal administration of OT or AVP may produce a global activation of both OT and AVP receptors.
“As such, it is important to consider the possibility that intranasal administration of OT or AVP produces a global activation of both OT and AVP receptors.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn hamsters, the lateral septum contains large numbers of V1aRs, but few, if any, AVP-containing fibers or cell bodies have been identified with immunohistochemistry.
“For example, in hamsters the lateral septum contains large numbers of V1aRs but few, if any, AVP containing fibers or cell bodies have been identified with immunohistochemistry [112; 113; 114; 115].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [112] Johnson AE Barberis C Albers HE Castration reduces vasopressin receptor binding in the hamster hypothalamus Brain Res 674 1995 153 8 7773686 source
Not checked in the free run.
- cites [113] Albers HE Rowland CM Ferris CF Arginine-vasopressin immunoreactivity is not altered by photoperiod or gonadal hormones in the Syrian hamster (Mesocricetus auratus) Brain Res 539 1991 137 142 2015498 source
Not checked in the free run.
- cites [114] Dubois-Dauphin M Pevet P Tribollet E Dreifuss JJ Vasopressin in the brain of the golden hamster: The distribution of vasopressin binding sites and of immunoreactivity to the vasopressin-related glycopeptide Journal of Comparative Neurology 300 1990 535 548 2148751 source
Not checked in the free run.
- cites [115] Young LJ Wang Z Cooper TT Albers HE Vasopressin (V1a) receptor binding, mRNA expression and transcriptional regulation by androgen in the Syrian hamster brain J Neuroendocrinol 12 2000 1179 85 11106975 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningCertain classes of social behavior are mediated by OTRs while other classes of social behavior are mediated by V1aRs.
“Although much more work needs to be done, these data suggest that certain classes of social behavior are mediated by OTRs while other classes of social behavior are mediated by V1aRs.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningSeveral different social behaviors can be influenced by both OT and AVP, but this influence appears to be mediated by only one of their receptors.
“Several different social behaviors can be influenced by both OT and AVP, but this influence appears to be mediated by only one of their receptors.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningHigh levels of intranasal oxytocin and vasopressin can cause substantial receptor cross-talk in both the periphery and the brain, leading to activation of many oxytocin and vasopressin receptors.
“These high levels of peptide have the potential to result in significant amounts of receptor cross-talk in the periphery as well as in the brain resulting in the activation of large numbers of OT and AVP receptors.”
Quote in the paperSubstantial claim- Rests on an assumption: Intranasal administration of oxytocin and vasopressin produces supraphysiological concentrations of these peptides in peripheral tissues.
May combine two claims.
Interpretationown dataAlthough OT and AVP increase social communication, social recognition, and social reward, the effects on social communication are mediated by V1aRs and their effects on social recognition and social reward are mediated by OTRs.
“For example, although OT and AVP increase social communication, social recognition, and social reward, the effects of these neuropeptides on social communication are mediated by V1aRs and their effects on social recognition and social reward are mediated by OTRs.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Intranasal administration of oxytocin and vasopressin produces supraphysiological concentrations of these peptides in peripheral tissues.
“Intranasal OT and AVP administration, which is currently in use in clinical trials, produces supraphysiological levels of these peptides in peripheral tissues.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Social cognition and reward processing can be mediated by OXT and OXTR, while social communication relies more on AVP and V1aR.
“For example, social cognition and reward processing can be mediated by OXT and OXTR, while social communication relies more on arginine-vasopressin (AVP) and its receptor (V1aR; Song and Albers, 2018).”
From Music's context-dependent influence on oxytocin, social bonding, and emotion regulation: a systematic review (2026) · cites this paper as Song and Albers, 2018
The Conclusions (section 6; page not available) say that social recognition and social reward are mediated by OTRs, while social communication is mediated by V1aRs. Section 3.1 reports that AVP was more potent than OT at inducing a form of social communication in hamsters. The claim broadens social recognition and social reward to cognition and reward processing generally; the paper also says both peptides can influence all three behaviors, so the peptide distinction is less clear-cut than the receptor distinction. (LLM, conf=0.84)
Experimental — accuracy not yet measuredOXT and AVP share structural similarities and can activate each other's receptors, and this 'cross-talk' is likely to participate in shaping social behaviors in musical contexts.
“Since OXT and AVP share structural similarities and can activate each other's receptors, this phenomenon, “cross-talk” (Song and Albers, 2018), is likely to participate in shaping social behaviors in musical contexts.”
From Music's context-dependent influence on oxytocin, social bonding, and emotion regulation: a systematic review (2026) · cites this paper as Song and Albers, 2018
The OXTR radioligand 125I-OVTA and the AVPR1a radioligand 125I-LVA bind to both receptor types when used in primate brain.
“These radioligands are now known to bind to both receptor types when they are used in primate brain37.”
From Effect of age and autism spectrum disorder on oxytocin receptor density in the human basal forebrain and midbrain (2018) · cites this paper as [48]
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works
The oxytocin receptor system: structure, function, and regulation
Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089 · see citing works
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688 · see citing works
Social amnesia in mice lacking the oxytocin gene
Ferguson, J. N., Young, L. J., Hearn, E. F., Matzuk, M. M., Insel, T. R., & Winslow, J. T. (2000) · Nature Genetics · doi:10.1038/77040 · Cited by 1,130 · see citing works
Landgraf, R., & Neumann, I. D. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.05.001 · Cited by 1,059 · see citing works
Evoked axonal oxytocin release in the central amygdala attenuates fear response
Knobloch, H. S., Charlet, A., Hoffmann, L. C., Eliava, M., Khrulev, S., Cetin, A. H., Osten, P., Schwarz, M. K., Seeburg, P. H., Stoop, R., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.030 · Cited by 1,049 · see citing works
Neumann, I. D., & Landgraf, R. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.08.004 · Cited by 954 · see citing works
Oxytocin and the Neural Mechanisms Regulating Social Cognition and Affiliative Behavior
Ross, H. E., & Young, L. J. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.004 · Cited by 856 · cited 1× · see citing works
“The endogenous release of OT and AVP in the brain may be the result of neuropeptide release from synaptic and/or non-synaptic regions of neurons, although the relative roles of these forms of release in different populations of OT and AVP-containing cells are controversial [93; 94; 95; 96].”
BackgroundPervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice
Takayanagi, Y., Yoshida, M., Bielsky, I. F., Ross, H. E., Kawamata, M., Onaka, T., Yanagisawa, T., Kimura, T., Matzuk, M. M., Young, L. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505312102 · Cited by 806 · see citing works
Oxytocin, vasopressin, and human social behavior
Heinrichs, M., von Dawans, B., & Domes, G. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.005 · Cited by 799 · see citing works
Intranasal Oxytocin: Myths and Delusions
Leng, G., & Ludwig, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.003 · Cited by 615 · cited 5× · see citing works
“OT/AVP receptors are found in many different peripheral tissues [2; 20].”
BackgroundInfluentialBielsky, I. F., Hu, S.-B., Szegda, K. L., Westphal, H., & Young, L. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300360 · Cited by 531 · see citing works
The vasopressinergic innervation of the brain in normal and castrated rats
DeVries, G. J., Buijs, R. M., van Leeuwen, F. W., Caffé, A. R., & Swaab, D. F. (1985) · Journal of Comparative Neurology · doi:10.1002/cne.902330206 · Cited by 522 · see citing works
Dumais, K. M., & Veenema, A. H. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.04.003 · Cited by 520 · cited 2× · see citing works
“In mammalian brain OTRs and V1aRs are robustly expressed in many regions but their distributions often differ [9; 21; 22] (Figure 3).”
BackgroundHerkenham, M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90268-5 · Cited by 520 · see citing works
Neuromodulation by Oxytocin and Vasopressin
Stoop, R. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.025 · Cited by 506 · see citing works
Ferris, C. F., Melloni Jr, R. H., Koppel, G., Perry, K. W., Fuller, R. W., & Delville, Y. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04331.1997 · Cited by 495 · see citing works
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02303.x · Cited by 423 · see citing works
Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 413 · see citing works
Vasopressin and oxytocin receptors in the central nervous system
Tribollet, E., & Barberis, C. (1996) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v10.i1.60 · Cited by 399 · see citing works
Oxytocin, vasopressin and sociality
CARTER, C., GRIPPO, A., POURNAJAFINAZARLOO, H., RUSCIO, M., & PORGES, S. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00427-5 · Cited by 380 · see citing works
Sala, M., Braida, D., Lentini, D., Busnelli, M., Bulgheroni, E., Capurro, V., Finardi, A., Donzelli, A., Pattini, L., Rubino, T., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.022 · Cited by 375 · see citing works
Morphology of vasopressin and oxytocin neurones and their central and vascular projections
Sofroniew, M. V. (1983) · Progress in Brain Research · doi:10.1016/s0079-6123(08)64378-2 · Cited by 370 · see citing works
Bielsky, I. F., Hu, S.-B., Ren, X., Terwilliger, E. F., & Young, L. J. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.031 · Cited by 367 · see citing works
Oxytocin enhances social recognition by modulating cortical control of early olfactory processing
Oettl, L.-L., Ravi, N., Schneider, M., Scheller, M. F., Schneider, P., Mitre, M., da Silva Gouveia, M., Froemke, R. C., Chao, M. V., Young, W. S., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.033 · Cited by 359 · see citing works
De Vries, G. J., & Panzica, G. C. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.050 · Cited by 346 · see citing works
Rilling, J. K., DeMarco, A. C., Hackett, P. D., Chen, X., Gautam, P., Stair, S., Haroon, E., Thompson, R., Ditzen, B., Patel, R., et al. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.09.022 · Cited by 343 · cited 1× · see citing works
“, BOLD fMRI responses) and cognition, at least in some cases although the effects of OT are more robust [84; 86; 87; 88; 89; 90].”
BackgroundDe Vries, G. J., Buds, R. M., & Swaab, D. F. (1981) · Brain Research · doi:10.1016/0006-8993(81)90989-6 · Cited by 319 · cited 1× · see citing works
“Indeed, the first demonstration of a sex difference in a neuropeptide system was identification of a sexually dimorphic innervation of the lateral septum by AVP fibers [10].”
BackgroundAssembling the puzzle: pathways of oxytocin signaling in the brain
Grinevich, V., Knobloch-Bollmann, H. S., Eliava, M., Busnelli, M., & Chini, B. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.013 · Cited by 309 · see citing works
Rilling, J. K., DeMarco, A. C., Hackett, P. D., Thompson, R., Ditzen, B., Patel, R., & Pagnoni, G. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.07.013 · Cited by 303 · see citing works
MANNING, M., STOEV, S., CHINI, B., DURROUX, T., MOUILLAC, B., & GUILLON, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00437-8 · Cited by 296 · see citing works
Albers, H. E. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.10.007 · Cited by 288 · see citing works
Self-citationA conditional knockout mouse line of the oxytocin receptor
Lee, H.-J., Caldwell, H. K., Macbeth, A. H., Tolu, S. G., & Young, W. S. (2008) · Endocrinology · doi:10.1210/en.2007-1710 · Cited by 269 · see citing works
Buijs, R. M., & Swaab, D. F. (1979) · Cell and Tissue Research · doi:10.1007/bf00233648 · Cited by 262 · see citing works
The Binding Site of Neuropeptide Vasopressin V1a Receptor
Mouillac, B., Chini, B., Balestre, M.-N., Elands, J., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Jard, S., & Barberis, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25771 · Cited by 262 · see citing works
Evolution of oxytocin pathways in the brain of vertebrates
Knobloch, H. S., & Grinevich, V. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00031 · Cited by 259 · see citing works
Vasopressin injected into the hypothalamus triggers a stereotypic behavior in golden hamsters
Ferris, C. F., Albers, H. E., Wesolowski, S. M., Goldman, B. D., & Luman, S. E. (1984) · Science · doi:10.1126/science.6538700 · Cited by 255 · see citing works
Self-citationJohnson, Z. V., & Young, L. J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.034 · Cited by 242 · see citing works
Neumann, I., Ludwig, M., Engelmann, M., Pittman, Q. J., & Landgraf, R. (2008) · Neuroendocrinology · doi:10.1159/000126604 · Cited by 236 · see citing works
The hamster - reproduction and behavior.
Siegel, H. I. (1985) · Plenum Press eBooks · Cited by 227 · see citing works
Engelmann, M., & Landgraf, R. (1994) · Physiology & Behavior · doi:10.1016/0031-9384(94)90022-1 · Cited by 225 · see citing works
Young, W. S., Li, J., Wersinger, S. R., & Palkovits, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.040 · Cited by 222 · see citing works
Interplay of oxytocin, vasopressin, and sex hormones in the regulation of social recognition
Gabor, C. S., Phan, A., Clipperton-Allen, A. E., Kavaliers, M., & Choleris, E. (2012) · Behavioral Neuroscience · doi:10.1037/a0026464 · Cited by 221 · see citing works
The oxytocin system in drug discovery for autism: Animal models and novel therapeutic strategies
Modi, M. E., & Young, L. J. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.12.010 · Cited by 218 · see citing works
Vasopressin and oxytocin release in the brain – a synaptic event
Buijs, R. M., & Heerikhuize, J. J. V. (1982) · Brain Research · doi:10.1016/0006-8993(82)90979-9 · Cited by 218 · see citing works
Oxytocin and vasopressin: powerful regulators of social behavior
Caldwell, H. K. (2017) · The Neuroscientist · doi:10.1177/1073858417708284 · Cited by 216 · see citing works
An intrinsic vasopressin system in the olfactory bulb is involved in social recognition
Tobin, V. A., Hashimoto, H., Wacker, D. W., Takayanagi, Y., Langnaese, K., Caquineau, C., Noack, J., Landgraf, R., Onaka, T., Leng, G., et al. (2010) · Nature · doi:10.1038/nature08826 · Cited by 213 · see citing works
Albers, H. E. (2015) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.07.001 · Cited by 200 · see citing works
Self-citationSabatier, N., Caquineau, C., Dayanithi, G., Bull, P., Douglas, A. J., Guan, X. M. M., Jiang, M., Van der Ploeg, L., & Leng, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10351.2003 · Cited by 190 · see citing works
Oxytocin-Induced Analgesia and Scratching Are Mediated by the Vasopressin-1A Receptor in the Mouse
Schorscher-Petcu, A., Sotocinal, S., Ciura, S., Dupre, A., Ritchie, J., Sorge, R. E., Crawley, J. N., Hu, S.-B., Nishimori, K., Young, L. J., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1594-10.2010 · Cited by 189 · see citing works
Vasopressin and oxytocin—their role in neurotransmission
Buijs, R. M. (1983) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(83)90056-6 · Cited by 189 · see citing works
Choleris, E., Little, S. R., Mong, J. A., Puram, S. V., Langer, R., & Pfaff, D. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700670104 · Cited by 183 · see citing works
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor
Chini, B., Mouillac, B., Ala, Y., Balestre, M. N., Trumpp‐Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., Manning, M., & Jard, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07211.x · Cited by 179 · see citing works
Neurotransmitters and peptides: Whispered secrets and public announcements
Leng, G., & Ludwig, M. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.159103 · Cited by 168 · see citing works
Legros, J.-J. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00018-x · Cited by 159 · see citing works
Feng, C., Hackett, P. D., DeMarco, A. C., Chen, X., Stair, S., Haroon, E., Ditzen, B., Pagnoni, G., & Rilling, J. K. (2015) · Brain Imaging and Behavior · doi:10.1007/s11682-014-9333-9 · Cited by 157 · see citing works
The Basic and Clinical Pharmacology of Nonpeptide Vasopressin Receptor Antagonists
Thibonnier, M., Coles, P., Thibonnier, A., & Shoham, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.175 · Cited by 146 · see citing works
Smith, C. J. W., Poehlmann, M. L., Li, S., Ratnaseelan, A. M., Bredewold, R., & Veenema, A. H. (2017) · Brain Structure and Function · doi:10.1007/s00429-016-1260-7 · Cited by 143 · see citing works
Oxytocin-immunoreactive terminals synapse on oxytocin neurones in the supraoptic nucleus
Theodosis, D. T. (1985) · Nature · doi:10.1038/313682a0 · Cited by 141 · see citing works
The action radius of oxytocin release in the mammalian CNS: from single vesicles to behavior
Chini, B., Verhage, M., & Grinevich, V. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.08.005 · Cited by 141 · cited 2× · see citing works
“The distance that non-synaptically released neuropeptides travel is uncertain, but is the subject of active investigation [96; 109].”
BackgroundVasopressin 1a receptor knockout mice have a subtle olfactory deficit but normal aggression
Wersinger, S. R., Caldwell, H. K., Martinez, L. A., Gold, P. W., Hu, S.-B., & Young, W. S. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00281.x · Cited by 139 · see citing works
Landgraf, R., Neumann, I., & Schwarzberg, H. (1988) · Brain Research · doi:10.1016/0006-8993(88)90689-0 · Cited by 137 · see citing works
Oxytocin enhances cranial visceral afferent synaptic transmission to the solitary tract nucleus
Peters, J. H., McDougall, S. J., Kellett, D. O., Jordan, D., Llewellyn-Smith, I. J., & Andresen, M. C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3419-08.2008 · Cited by 135 · see citing works
Thibonnier, M., Preston, J. A., Dulin, N. O., Wilkins, P. L., Berti‐Mattera, L. N., & Mattera, R. (1997) · Endocrinology · doi:10.1210/endo.138.10.5432 · Cited by 135 · see citing works
The neurohypophysial endocrine regulatory cascade: precursors, mediators, receptors, and effectors
Acher, R., & Chauvet, J. (1995) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1995.1009 · Cited by 135 · see citing works
Vasopressin innervation of the mouse ( <i>Mus musculus</i> ) brain and spinal cord
Rood, B. D., & De Vries, G. J. (2011) · Journal of Comparative Neurology · doi:10.1002/cne.22635 · Cited by 134 · see citing works
Veenema, A. H., Bredewold, R., & De Vries, G. J. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.10.002 · Cited by 129 · see citing works
Oxytocin, vasopressin, and the motivational forces that drive social behaviors
Caldwell, H. K., & Albers, H. E. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_390 · Cited by 129 · see citing works
Self-citationRamos, L., Hicks, C., Kevin, R., Caminer, A., Narlawar, R., Kassiou, M., & McGregor, I. S. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.125 · Cited by 128 · see citing works
Åkerlund, M., Bossmar, T., Brouard, R., Kostrzewska, A., Laudanski, T., Lemancewicz, A., Gal, C. S., & Steinwall, M. (1999) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1999.tb08112.x · Cited by 123 · see citing works
Terranova, J. I., Song, Z., Larkin, T. E., Hardcastle, N., Norvelle, A., Riaz, A., & Albers, H. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610446113 · Cited by 123 · see citing works
Self-citationOxytocin and Vasopressin: Genetics and Behavioral Implications
Caldwell, H. K., & Young, W. S. (2006) · Springer eBooks · doi:10.1007/0-387-30395-2_25 · Cited by 113 · see citing works
Oxytocin and vasopressin: genetics and behavioral implications
Caldwell, H. K., & Young, W. S. (2006) · Handbook of Neurochemistry and Molecular Neurobiology · doi:10.1007/978-0-387-30381-9_25 · Cited by 113 · see citing works
A V1-like receptor mediates vasopressin-induced flank marking behavior in hamster hypothalamus
Albers, H., Pollock, J., Simmons, W., & Ferris, C. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-07-02085.1986 · Cited by 112 · see citing works
Self-citationBossmar, T., Åkerlund, M., Fantoni, G., Szamatowicz, J., Melin, P., & Maggi, M. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90415-4 · Cited by 112 · see citing works
Voorn, P., & Buijs, R. M. (1983) · Brain Research · doi:10.1016/0006-8993(83)90809-0 · Cited by 112 · see citing works
Song, Z., McCann, K. E., McNeill, J. K., Larkin, T. E., Huhman, K. L., & Albers, H. E. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.08.005 · Cited by 111 · see citing works
Self-citationVasopressin in the septal area of the golden hamster controls scent marking and grooming
Irvin, R. W., Szot, P., Dorsa, D. M., Potegal, M., & Ferris, C. F. (1990) · Physiology & Behavior · doi:10.1016/0031-9384(90)90213-n · Cited by 105 · see citing works
Intranasal oxytocin, but not vasopressin, augments neural responses to toddlers in human fathers
Li, T., Chen, X., Mascaro, J., Haroon, E., & Rilling, J. K. (2017) · Hormones and Behavior · doi:10.1016/j.yhbeh.2017.01.006 · Cited by 105 · see citing works
Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors
Busnelli, M., Bulgheroni, E., Manning, M., Kleinau, G., & Chini, B. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.202994 · Cited by 102 · see citing works
Song, Z., Borland, J. M., Larkin, T. E., O’Malley, M., & Albers, H. E. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.09.001 · Cited by 101 · see citing works
Self-citationThe vasopressin 1b receptor and the neural regulation of social behavior
Stevenson, E. L., & Caldwell, H. K. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.11.009 · Cited by 100 · see citing works
Effect of photoperiod on vasopressin-induced aggression in Syrian hamsters
Caldwell, H. K., & Albers, H. E. (2004) · Hormones and Behavior · doi:10.1016/j.yhbeh.2004.04.006 · Cited by 97 · see citing works
Behavioural impact of intraseptally released vasopressin and oxytocin in rats
Englemann, M., Wotjak, C. T., Ebner, K., & Landgraf, R. (2000) · Experimental Physiology · doi:10.1111/j.1469-445x.2000.tb00015.x · Cited by 94 · see citing works
Hawthorn, J., Ang, V. T. Y., & Jenkins, J. S. (1985) · Brain Research · doi:10.1016/0006-8993(85)91093-5 · Cited by 93 · see citing works
[3H]-[Thr4,Gly7]OT: a highly selective ligand for central and peripheral OT receptors
Elands, J., Barberis, C., & Jard, S. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.254.1.e31 · Cited by 88 · see citing works
Young, L. J., Wang, Z., Cooper, T. T., & Albers, H. E. (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00573.x · Cited by 88 · see citing works
Self-citationMolecular biology of vasopressin receptors
LOLAIT, S. J., O'CARROLL, A., & BROWNSTEIN, M. J. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44688.x · Cited by 87 · cited 14× · see citing works
“The selectivity of OT and AVP for OTRs, V1aRs, V1bRs, and V2Rs has been examined using a variety of in vitro and in vivo assays ranging from measurements of cellular activity to overt behavior.”
BackgroundInfluentialGutzler, S. J., Karom, M., Erwin, W. D., & Albers, H. E. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07190.x · Cited by 86 · see citing works
Dubois‐Dauphin, M., Pevet, P., Triboilet, E., & Dreif'Uss, J. J. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.903000408 · Cited by 85 · see citing works
Distribution and developmental changes in vasopressin V2 receptor mRNA in rat brain
Kato, Y., Igarashi, N., Hirasawa, A., Tsujimoto, G., & Kobayashi, M. (1995) · Differentiation · doi:10.1046/j.1432-0436.1995.5930163.x · Cited by 82 · see citing works
Chen, X., Hackett, P. D., DeMarco, A. C., Feng, C., Stair, S., Haroon, E., Ditzen, B., Pagnoni, G., & Rilling, J. K. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-015-9411-7 · Cited by 81 · see citing works
Fuxe, K., Borroto-Escuela, D. O., Romero-Fernandez, W., Ciruela, F., Manger, P., Leo, G., Díaz-Cabiale, Z., & Agnati, L. F. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.062 · Cited by 81 · see citing works
Oxytocin and the oxytocin receptor underlie intrastrain, but not interstrain, social recognition
Macbeth, A. H., Lee, H. ‐., Edds, J., & Young, W. S. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2009.00506.x · Cited by 81 · see citing works
Editorial comment: Oxytocin, vasopressin and social behavior
Young, L. J., & Flanagan-Cato, L. M. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.02.019 · Cited by 81 · see citing works
Buijs, R. M. (1980) · Journal of Histochemistry & Cytochemistry · doi:10.1177/28.4.6989899 · Cited by 81 · see citing works
Oxytocin and behavior: lessons from knockout mice
Caldwell, H. K., Aulino, E. A., Freeman, A. R., Miller, T. V., & Witchey, S. K. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22431 · Cited by 79 · see citing works
Kubo, A., Shinoda, M., Katagiri, A., Takeda, M., Suzuki, T., Asaka, J., Yeomans, D. C., & Iwata, K. (2017) · Pain · doi:10.1097/j.pain.0000000000000808 · Cited by 79 · see citing works
Distribution and developmental change of vasopressin V1A and V2 receptor mRNA in rats
Hirasawa, A., Hashimoto, K., & Tsujimoto, G. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90226-7 · Cited by 78 · see citing works
Molecular characterization of a cloned human oxytocin receptor
Kimura, T., Makino, Y., Saji, F., Takemura, M., Inoue, T., Kikuchi, T., Kubota, Y., Azuma, C., Nobunaga, T., Tokugawa, Y., et al. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1310385 · Cited by 77 · see citing works
Distribution of oxytocin and co-localization with arginine vasopressin in the brain of mice
Otero‐García, M., Agustín‐Pavón, C., Lanuza, E., & Martínez‐Garciá, F. (2015) · Brain Structure and Function · doi:10.1007/s00429-015-1111-y · Cited by 76 · see citing works
Hicks, C., Ramos, L., Reekie, T., Misagh, G. H., Narlawar, R., Kassiou, M., & McGregor, I. S. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12613 · Cited by 76 · see citing works
Derick, S., Cheng, L. L., Voirol, M. J., Stoev, S., Giacomini, M., Wo, N. C., Szeto, H. H., Ben Mimoun, M., Andres, M., Gaillard, R. C., et al. (2002) · Endocrinology · doi:10.1210/en.2002-220363 · Cited by 76 · see citing works
Schlosser, S. F., Almeida, O. F., Patchev, V. K., Yassouridis, A., & Elands, J. (1994) · Endocrinology · doi:10.1210/endo.135.5.7956927 · Cited by 75 · see citing works
Inhibition of vasopressin-stimulated flank marking behavior by V1-receptor antagonists
Ferris, C. F., Singer, E. A., Meenan, D. M., & Elliott Albers, H. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90092-1 · Cited by 74 · see citing works
Self-citationDiBenedictis, B. T., Nussbaum, E. R., Cheung, H. K., & Veenema, A. H. (2017) · Journal of Comparative Neurology · doi:10.1002/cne.24216 · Cited by 74 · see citing works
Qiu, F., Qiu, C., Cai, H., Liu, T., Qu, Z., Yang, Z., Li, J., Zhou, Q., & Hu, W. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12635 · Cited by 67 · see citing works
Busnelli, M., Kleinau, G., Muttenthaler, M., Stoev, S., Manning, M., Bibic, L., Howell, L. A., McCormick, P. J., Di Lascio, S., Braida, D., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00564 · Cited by 67 · see citing works
Gupta, J., Russell, R. J., Wayman, C. P., Hurley, D., & Jackson, V. M. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.226 · Cited by 66 · see citing works
Castration reduces vasopressin receptor binding in the hamster hypothalamus
Johnson, A. E., Barberis, C., & Elliott Albers, H. (1995) · Brain Research · doi:10.1016/0006-8993(95)00010-n · Cited by 65 · see citing works
Self-citationOxytocin and vasopressin modulate the social response to threat: a preclinical study
Bowen, M. T., & McGregor, I. S. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000388 · Cited by 63 · see citing works
Non-synaptic and dendritic exocytosis from dense-cored vesicles in the suprachiasmatic nucleus
Castel, M., Morris, J., & Belenky, M. (1996) · NeuroReport · doi:10.1097/00001756-199601310-00040 · Cited by 61 · see citing works
Albers, H. E., Rowland, C. M., & Ferris, C. F. (1991) · Brain Research · doi:10.1016/0006-8993(91)90696-s · Cited by 59 · see citing works
Self-citationHuhman, K. L., Babagbemi, T. O., & Albers, H. E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00018-l · Cited by 56 · see citing works
Self-citationGriffin, G. D., Ferri‐Kolwicz, S. L., Reyes, B. A. S., Van Bockstaele, E. J., & Flanagan‐Cato, L. M. (2010) · Journal of Comparative Neurology · doi:10.1002/cne.22470 · Cited by 56 · see citing works
Translating Oxytocin Neuroscience to the Clinic: A National Institute of Mental Health Perspective
Insel, T. R. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.002 · Cited by 56 · see citing works
α‐Melanocyte‐Stimulating Hormone and Oxytocin: A Peptide Signalling Cascade in the Hypothalamus
Sabatier, N. (2006) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01464.x · Cited by 54 · see citing works
Hennessey, A. C., Carol Whitman, D., & elliott Albers, H. (1992) · Brain Research · doi:10.1016/0006-8993(92)90379-n · Cited by 52 · see citing works
Self-citationTerrillon, S., Cheng, L., Stoev, S. B., Mouillac, B., Barberis, C., Manning, M., & Durroux, T. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010526+ · Cited by 48 · see citing works
Kawamata, M., Mitsui-Saito, M., Kimura, T., Takayanagi, Y., Yanagisawa, T., & Nishimori, K. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01914-9 · Cited by 47 · see citing works
Mahoney, P. D., Koh, E. T., Irvin, R. W., & Ferris, C. F. (1990) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1990.tb00840.x · Cited by 47 · see citing works
Song, Z., Larkin, T. E., Malley, M. O., & Albers, H. E. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2016.02.004 · Cited by 47 · see citing works
Self-citationSeptal oxytocin administration impairs peer affiliation via V1a receptors in female meadow voles
Anacker, A. M. J., Christensen, J. D., LaFlamme, E. M., Grunberg, D. M., & Beery, A. K. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.02.025 · Cited by 44 · see citing works
Ragnauth, A. K., Goodwillie, A., Brewer, C., Muglia, L. J., Pfaff, D. W., & Kow, L.-M. (2004) · Neuroendocrinology · doi:10.1159/000081844 · Cited by 41 · see citing works
Fujiwara, Y., Hiroyama, M., Sanbe, A., Yamauchi, J., Tsujimoto, G., & Tanoue, A. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.06864 · Cited by 36 · see citing works
Gal, C. S.-L., Raufaste, D., Derick, S., Blankenstein, J., Allen, J., Pouzet, B., Pascal, M., Wagnon, J., & Ventura, M. A. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00062.2007 · Cited by 35 · see citing works
Hawtin, S. R., Wesley, V. J., Parslow, R. A., Patel, S., & Wheatley, M. (2000) · Biochemistry · doi:10.1021/bi0013400 · Cited by 32 · see citing works
Roles of arginine vasotocin receptors in the brain and pituitary of submammalian vertebrates
(2013) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-407696-9.00004-x · Cited by 30 · see citing works
Oxytocin and vasopressin modulate risk-taking
Patel, N., Grillon, C., Pavletic, N., Rosen, D., Pine, D. S., & Ernst, M. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.11.018 · Cited by 29 · see citing works
Postnatal expression of V2 vasopressin receptor splice variants in the rat cerebellum
Vargas, K. J., Sarmiento, J., Ehrenfeld, P., Añazco, C. C., Villanueva, C. I., Carmona, P., Brenet, M., Navarro, J., Müller‐Esterl, W., & González, C. B. (2009) · Differentiation · doi:10.1016/j.diff.2008.11.002 · Cited by 26 · see citing works
Nakamura, K., Fujiwara, Y., Mizutani, R., Sanbe, A., Miyauchi, N., Hiroyama, M., Yamauchi, J., Yamashita, T., Nakamura, S., Mori, T., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1528 · Cited by 25 · see citing works
Loyens, E., Vermoesen, K., Schallier, A., Michotte, Y., & Smolders, I. (2012) · Brain Research · doi:10.1016/j.brainres.2011.11.059 · Cited by 25 · see citing works
Ramos, L., Hicks, C., Caminer, A., Couto, K., Narlawar, R., Kassiou, M., & McGregor, I. S. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.10.002 · Cited by 25 · see citing works
Neuroactive proteins and peptides
Lim, R., & Lajtha, Á. (2006) · Springer eBooks · Cited by 24 · see citing works
Oxytocin immunoreactivity in the hypothalamus of female hamsters
Whitman, D. C., & Albers, H. E. (1998) · Cell and Tissue Research · doi:10.1007/s004410050993 · Cited by 24 · see citing works
Self-citationHicks, C., Ramos, L., Reekie, T. A., Narlawar, R., Kassiou, M., & McGregor, I. S. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3902-5 · Cited by 23 · see citing works
Hicks, C., Ramos, L., Dampney, B., Baracz, S. J., McGregor, I. S., & Hunt, G. E. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.10.005 · Cited by 22 · see citing works
Veinante, P., & Freund-Mercier, M.-J. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970707)383:3
Flagged first, then by citations
4 of the 142 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Oxytocin, Neural Plasticity, and Social Behavior
Froemke, R. C., & Young, L. J. (2021) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-102320-102847 · Cited by 487 · see citing works
“Some actions of oxytocin are mediated via vasopressin receptors and vice versa (Chini et al. 2008, Schorscher-Petcu et al. 2010, Xiao et al. 2017, Song & Albers 2018).”
BackgroundIs oxytocin “nature’s medicine”
Carter, C. S., Kenkel, W. M., MacLean, E. L., Wilson, S. R., Perkeybile, A. M., Yee, J. R., Ferris, C. F., Nazarloo, H. P., Porges, S. W., Davis, J. M., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019398 · Cited by 394 · see citing works
AMPK: Potential Therapeutic Target for Ischemic Stroke
Jiang, S., Li, T. X., Ji, T., Yi, W., Yang, Z. P., Wang, S., Yang, Y., & Gu, C. (2018) · Theranostics · doi:10.7150/thno.25674 · Cited by 252 · see citing works
Jensen-Cody, S. O., Flippo, K. H., Claflin, K. E., Yavuz, Y., Sapouckey, S. A., Walters, G. C., Usachev, Y. M., Atasoy, D., Gillum, M. P., & Potthoff, M. J. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.008 · Cited by 166 · see citing works
Universal nomenclature for oxytocin–vasotocin ligand and receptor families
Theofanopoulou, C., Gedman, G. L., Cahill, J. A., Boeckx, C. A., & Jarvis, E. D. (2021) · Nature · doi:10.1038/s41586-020-03040-7 · Cited by 122 · see citing works
Vasopressin and its analogues in shock states: a review
Demiselle, J., Fage, N., Radermacher, P., & Asfar, P. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-0628-2 · Cited by 133 · see citing works
Sex-dependent regulation of social reward by oxytocin: an inverted U hypothesis
Borland, J. M., Rilling, J. K., Frantz, K. J., & Albers, H. E. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0129-2 · Cited by 116 · see citing works
Self-citationSteinman, M. Q., Duque-Wilckens, N., & Trainor, B. C. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.10.008 · Cited by 105 · see citing works
Detection, processing and reinforcement of social cues: regulation by the oxytocin system
Menon, R., & Neumann, I. D. (2023) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00759-w · Cited by 100 · see citing works
Role of oxytocin in the control of stress and food intake
Onaka, T., & Takayanagi, Y. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12700 · Cited by 98 · see citing works
Ellis, B. J., Horn, A. J., Carter, C. S., van IJzendoorn, M. H., & Bakermans‐Kranenburg, M. J. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.101985 · Cited by 103 · see citing works
The Role of Oxytocin in Cardiovascular Protection
Jankowski, M., Broderick, T. L., & Gutkowska, J. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.02139 · Cited by 101 · see citing works
Freeman, S. M., Palumbo, M. C., Lawrence, R. H., Smith, A. L., Goodman, M. M., & Bales, K. L. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0315-3 · Cited by 82 · see citing works
The Effects of Oxytocin on Appetite Regulation, Food Intake and Metabolism in Humans
Kerem, L., & Lawson, E. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147737 · Cited by 94 · see citing works
Links between the neurobiology of oxytocin and human musicality
Harvey, A. R. (2020) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.00350 · Cited by 85 · see citing works
Dai, Y., Zhang, H., Schön, M., Böckers, T. M., Han, S., Han, J., & Zhang, R. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00355 · Cited by 82 · see citing works
Sex differences in the regulation of offensive aggression and dominance by arginine-vasopressin
Terranova, J. I., Ferris, C. F., & Albers, H. E. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00308 · Cited by 85 · see citing works
Self-citationPerceptual mechanisms of social affiliation in zebrafish
Nunes, A. R., Carreira, L. I. F., Anbalagan, S., Blechman, J., Levkowitz, G., & Oliveira, R. F. (2020) · Scientific Reports · doi:10.1038/s41598-020-60154-8 · Cited by 72 · see citing works
The role of oxytocin and vasopressin dysfunction in cognitive impairment and mental disorders
Abramova, O. V., Zorkina, Y., Ushakova, V. M., Zubkov, E. A., Morozova, A. Y., & Chekhonin, V. P. (2020) · Neuropeptides · doi:10.1016/j.npep.2020.102079 · Cited by 74 · see citing works
Oxytocin and vasopressin: signalling, behavioural modulation and potential therapeutic effects
Rae, M., Lemos Duarte, M., Gomes, I., Camarini, R., & Devi, L. A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15481 · Cited by 72 · see citing works
Wang, P., Wang, S. C., Yang, H.-P., Lv, C., Jia, S., Liu, X., Wang, X., Meng, D., Qin, D., Zhu, H. F., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00454 · Cited by 73 · see citing works
Kingsbury, M. A., & Bilbo, S. D. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100794 · Cited by 64 · see citing works
Oxytocin Receptors Regulate Social Preference in Zebrafish
Landin, J., Hovey, D., Xu, B., Lagman, D., Zettergren, A., Larhammar, D., Kettunen, P., & Westberg, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-61073-4 · Cited by 63 · see citing works
Biological principles for music and mental health
Bowling, D. L. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02671-4 · Cited by 64 · see citing works
Sexually dimorphic role of oxytocin in medaka mate choice
Yokoi, S., Naruse, K., Kamei, Y., Ansai, S., Kinoshita, M., Mito, M., Iwasaki, S., Inoue, S., Okuyama, T., Nakagawa, S., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921446117 · Cited by 62 · see citing works
Rigney, N., Beaumont, R., & Petrulis, A. (2020) · Hormones and Behavior · doi:10.1016/j.yhbeh.2020.104715 · Cited by 47 · see citing works
Sparapani, S., Millet-Boureima, C., Oliver, J., Mu, K., Hadavi, P., Kalostian, T., Ali, N., Avelar, C. M., Bardies, M., Barrow, B., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9010089 · Cited by 63 · see citing works
Mitochondria, Oxytocin, and Vasopressin: Unfolding the Inflammatory Protein Response
Bordt, E. A., Smith, C. J., Demarest, T. G., Bilbo, S. D., & Kingsbury, M. A. (2019) · Neurotoxicity Research · doi:10.1007/s12640-018-9962-7 · Cited by 58 · see citing works
Modulation of social behavior by distinct vasopressin sources
Rigney, N., Vries, G. J. D., & Petrulis, A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1127792 · Cited by 61 · see citing works
Smith, C. J. W., DiBenedictis, B. T., & Veenema, A. H. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.02.001 · Cited by 59 · see citing works
Oxytocin and love: myths, metaphors and mysteries.
Carter, C. S. (2022) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2021.100107 · Cited by 57 · see citing works
Madrid, J. E., Parker, K. J., & Ophir, A. G. (2020) · Advances in the study of behavior · doi:10.1016/bs.asb.2020.02.001 · Cited by 55 · see citing works
Swaab, D. F., & Bao, A. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64123-6.00023-0 · Cited by 56 · see citing works
Role of oxytocin in the ventral tegmental area in social reinforcement
Borland, J. M., Grantham, K. N., Aiani, L. M., Frantz, K. J., & Albers, H. E. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.028 · Cited by 51 · see citing works
Self-citationEngel, S., Laufer, S., Miller, R., Niemeyer, H., Knaevelsrud, C., & Schumacher, S. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100775 · Cited by 50 · see citing works
The interplay of oxytocin and sex hormones
Quintana, D. S., Glaser, B. D., Kang, H., Kildal, E. S.-M., Audunsdottir, K., Sartorius, A. M., & Barth, C. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105765 · Cited by 54 · see citing works
Contractility of the epididymal duct: function, regulation and potential drug effects
Elfgen, V., Mietens, A., Mewe, M., Hau, T., & Middendorff, R. (2018) · Reproduction · doi:10.1530/rep-17-0754 · Cited by 52 · see citing works
Role of oxytocin in parental behaviour
Olazábal, D. E. (2018) · Journal of Neuroendocrinology · doi:10.1111/jne.12594 · Cited by 47 · see citing works
Rigney, N., Whylings, J., de Vries, G. J., & Petrulis, A. (2021) · Neuroendocrinology · doi:10.1159/000509421 · Cited by 42 · see citing works
The impact of sex as a biological variable in the search for novel antidepressants
Williams, A. V., & Trainor, B. C. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.05.003 · Cited by 40 · see citing works
Borie, A. M., Dromard, Y., Guillon, G., Olma, A., Manning, M., Muscatelli, F., Desarménien, M. G., & Jeanneteau, F. (2021) · Journal of Clinical Investigation · doi:10.1172/jci144450 · Cited by 41 · see citing works
A line attractor encoding a persistent internal state requires neuropeptide signaling
Mountoufaris, G., Nair, A., Yang, B., Kim, D.-W., Vinograd, A., Kim, S., Linderman, S. W., & Anderson, D. J. (2024) · Cell · doi:10.1016/j.cell.2024.08.015 · Cited by 48 · see citing works
Stadler, B., Whittaker, M. R., Exintaris, B., & Middendorff, R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.565731 · Cited by 41 · see citing works
Cid-Jofré, V., Moreno, M., Reyes-Parada, M. I., & Renard, G. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112077 · Cited by 39 · see citing works
Neurobiology of Aggression—Review of Recent Findings and Relationship with Alcohol and Trauma
Fritz, M., Soravia, S.-M., Dudeck, M., Malli, L., & Fakhoury, M. (2023) · Biology · doi:10.3390/biology12030469 · Cited by 40 · see citing works
The role of vasopressin in olfactory and visual processing
Wacker, D. W., & Ludwig, M. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2867-1 · Cited by 36 · see citing works
Vasopressin and alcohol: a multifaceted relationship
Harper, K. M., Knapp, D. J., Criswell, H. E., & Breese, G. R. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5099-x · Cited by 34 · see citing works
Althammer, F., Muscatelli, F., Grinevich, V., & Schaaf, C. P. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02054-1 · Cited by 34 · see citing works
Taylor, J. H., Walton, J. C., McCann, K. E., Norvelle, A., Liu, Q., Vander Velden, J. W., Borland, J. M., Hart, M., Jin, C., Huhman, K. L., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121037119 · Cited by 35 · see citing works
Self-citationSchmidt, M., Braun, K., Brandwein, C., Rossetti, A. C., Ciurana, S. G., Riva, M. A., Deuschle, M., Bock, J., Gass, P., & Gröger, N. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.06.027 · Cited by 33 · see citing works
Beyond romance: Neural and genetic correlates of altruism in pair-bonds.
Acevedo, B. P., Poulin, M. J., & Brown, L. L. (2019) · Behavioral Neuroscience · doi:10.1037/bne0000293 · Cited by 35 · see citing works
Zhang, X., Zhao, F., Wang, C., Zhang, J., Bai, Y., Zhou, F., Wang, Z.-J., Wu, M., Yang, W., Guo, J., et al. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00434-0 · Cited by 31 · see citing works
Oxytocin and oxygen: the evolution of a solution to the ‘stress of life’
Carter, C. S., & Kingsbury, M. A. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0054 · Cited by 32 · see citing works
Neuroimaging and behavioral evidence of sex-specific effects of oxytocin on human sociality
Procyshyn, T. L., Dupertuys, J., & Bartz, J. A. (2024) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2024.06.010 · Cited by 29 · see citing works
Salcedo‐Arellano, M. J., Cabal-Herrera, A. M., Punatar, R., Clark, C. J., Romney, C. A., & Hagerman, R. J. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00968-6 · Cited by 30 · see citing works
Female HPA axis displays heightened sensitivity to pre-pubertal stress
Brydges, N. M., Best, C., & Thomas, K. L. (2019) · Stress · doi:10.1080/10253890.2019.1658738 · Cited by 30 · see citing works
Emerging pharmacological therapies in fragile X syndrome and autism
Yamasue, H., Aran, A. A., & Berry‐Kravis, E. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000703 · Cited by 27 · see citing works
Runyan, A. M., Lengel, D., Huh, J. W., Barson, J. R., & Raghupathi, R. (2021) · eNeuro · doi:10.1523/eneuro.0061-21.2021 · Cited by 27 · see citing works
The Oxytocin System and Implications for Oxytocin Deficiency in Hypothalamic-Pituitary Disease
Aulinas, A., & Lawson, E. A. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf008 · Cited by 30 · see citing works
Nonapeptides mediate trade-offs in parental care strategy
DeAngelis, R., Dodd, L., & Rhodes, J. S. (2020) · Hormones and Behavior · doi:10.1016/j.yhbeh.2020.104717 · Cited by 25 · see citing works
Oxytocin structure and function in New World monkeys: from pharmacology to behavior
Mustoe, A. C., Taylor, J. H., & French, J. A. (2018) · Integrative Zoology · doi:10.1111/1749-4877.12318 · Cited by 25 · see citing works
Holman, P. J., Ellis, L. A., Morgan, E., & Weinberg, J. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.08.004 · Cited by 26 · see citing works
Medial Amygdala Arginine Vasopressin Neurons Regulate Innate Aversion to Cat Odors in Male Mice
Tong, W. H., Abdulai-Saiku, S., & Vyas, A. (2020) · Neuroendocrinology · doi:10.1159/000508862 · Cited by 25 · see citing works
Alanazi, M. M., Havránek, T., Bakoš, J., et al. (2020) · Endocrine Regulations · doi:10.2478/enr-2020-0020 · Cited by 26 · see citing works
The Role of Oxytocin in Early-Life-Stress-Related Neuropsychiatric Disorders
Jin, Y., Song, D. F., Yan, Y., Quan, Z., & Qing, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310430 · Cited by 30 · see citing works
Rigney, N., Campos‐Lira, E., Kirchner, M. K., Wei, W., Belkasim, S., Beaumont, R., Singh, S. P., Suarez, S. G., Hartswick, D., Stern, J. E., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2319641121 · Cited by 23 · see citing works
Razo, R. A., Vázquez, M. D. L. V., Turcanu, P., Legrand, M., Floch, M., Weinstein, T. A. R., Goetze, L. R., Freeman, S. M., BAXTER, A. B., Witczak, L. R., et al. (2022) · Hormones and Behavior · doi:10.1016/j.yhbeh.2022.105126 · Cited by 23 · see citing works
Social zebrafish: Danio rerio as an emerging model in social neuroendocrinology
Kareklas, K., Teles, M. C., Nunes, A. R., & Oliveira, R. F. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13280 · Cited by 23 · see citing works
Differential fate between oxytocin and vasopressin cells in the developing mouse brain
Soumier, A., Habart, M., Lio, G., Demily, C., & Angela Sirigu, B. (2021) · iScience · doi:10.1016/j.isci.2021.103655 · Cited by 20 · see citing works
Szczepanska‐Sadowska, E. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214414 · Cited by 22 · see citing works
The distribution of neuroligin4, an autism-related postsynaptic molecule, in the human brain
Toya, A., Fukada, M., Aoki, E., Matsuki, T., Ueda, M., Eda, S., Hashizume, Y., Iio, A., Masaki, S., & Nakayama, A. (2023) · Molecular Brain · doi:10.1186/s13041-023-00999-y · Cited by 22 · see citing works
Oxytocin therapy in hypopituitarism: Challenges and opportunities
Bhargava, R., Daughters, K., & Rees, A. (2018) · Clinical Endocrinology · doi:10.1111/cen.13909 · Cited by 22 · see citing works
Harper, K. M., Knapp, D. J., Butler, R. K., Cook, C. A., Criswell, H. E., Stuber, G. D., & Breese, G. R. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14163 · Cited by 21 · see citing works
Freeman, A. R., Aulino, E. A., Caldwell, H. K., & Ophir, A. G. (2020) · Journal of Neuroendocrinology · doi:10.1111/jne.12828 · Cited by 19 · see citing works
Borie, A. M., Theofanopoulou, C., & Andari, E. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819973-2.00009-5 · Cited by 18 · see citing works
Raymond, J. S., Rehn, S., Hoyos, C. M., & Bowen, M. T. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.016 · Cited by 21 · see citing works
Inoue, Y., Miwa, H., Hori, K., Kaneko, R., Morimoto, Y., Koike, E., Asami, J., Kamijo, S., Yamada, M., Hoshino, M., et al. (2022) · eNeuro · doi:10.1523/eneuro.0423-21.2022 · Cited by 18 · see citing works
Sex Differences in Social Cognition
Paletta, P., Bass, N., Aspesi, D., & Choleris, E. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_325 · Cited by 19 · see citing works
Vaidyanathan, R., & Hammock, E. A. D. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12821 · Cited by 20 · see citing works
Lyu, L. K., Li, J. S., Wang, X. J., Yao, Y. J., Li, J. F., Li, Y., Wen, H. S., & Qi, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.617580 · Cited by 20 · see citing works
Mohan, S., McCloskey, A. G., McKillop, A. M., Flatt, P. R., Irwin, N., & Moffett, R. C. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129811 · Cited by 16 · see citing works
Trofimova, I. N., & Gaykalova, A. A. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.781631 · Cited by 18 · see citing works
Frehner, S. S., Dooley, K. T., Palumbo, M. C., Smith, A. L., Goodman, M. M., Bales, K. L., & Freeman, S. M. (2022) · Philosophical Transactions of the Royal Society B · doi:10.1098/rstb.2021.0118 · Cited by 18 · see citing works
Oztan, O., Zyga, O., Stafford, D. E. J., & Parker, K. J. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104870 · Cited by 18 · see citing works
Extrahippocampal Contributions to Social Memory: The Role of Septal Nuclei
Shivakumar, A. B., Mehak, S. F., Jijimon, F., & Gangadharan, G. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.04.018 · Cited by 17 · see citing works
Oxytocin and the Role of Fluid Restriction in MDMA-Induced Hyponatremia
Atila, C., Straumann, I., Vizeli, P., Beck, J., Monnerat, S., Holze, F., Liechti, M. E., & Christ‐Crain, M. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.45278 · Cited by 17 · see citing works
Khodagholi, F., Maleki, A., Motamedi, F., Mousavi, M. A., Rafiei, S., & Moslemi, M. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-01003-0 · Cited by 17 · see citing works
Combination therapy with neuropeptides for the treatment of anxiety disorder
Gupta, P. R., & Prabhavalkar, K. S. (2021) · Neuropeptides · doi:10.1016/j.npep.2021.102127 · Cited by 17 · see citing works
H2S and Oxytocin Systems in Early Life Stress and Cardiovascular Disease
McCook, O., Denoix, N., Radermacher, P., Waller, C., & Merz, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163484 · Cited by 16 · see citing works
Oxytocin in neurodevelopmental disorders: Autism spectrum disorder and Prader-Willi syndrome
Josselsohn, A., Zhao, Y., Espinoza, D., & Hollander, E. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108734 · Cited by 16 · see citing works
Oxytocin, Vasopressin and Stress: A Hormetic Perspective
Nazarloo, H. P., Kingsbury, M. A., Lamont, H., Dale, C. V., Nazarloo, P., Davis, J. M., Porges, E. C., Cuffe, S. P., & Carter, C. S. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47080632 · Cited by 19 · see citing works
Microbes, oxytocin and stress: Converging players regulating eating behavior
Cuesta‐Marti, C., Uhlig, F., Muguerza, B., Hyland, N. P., Clarke, G. A., & Schellekens, H. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13243 · Cited by 15 · see citing works
Validity of mental and physical stress models
Hendry, E., McCallister, B., Elman, D. J., Freeman, R. L., Borsook, D., & Elman, I. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105566 · Cited by 17 · see citing works
Leu8 and Pro8 oxytocin agonism differs across human, macaque, and marmoset vasopressin 1a receptors
Mustoe, A. C., Schulte, N. A., Taylor, J. H., French, J. A., & Toews, M. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-52024-9 · Cited by 15 · see citing works
Complexity of the Hypothalamic Oxytocin System and its Involvement in Brain Functions and Diseases
Cui, X., & Xiao, L. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01424-1 · Cited by 16 · see citing works
Taylor, J. H., McCann, K. E., Ross, A. P., & Albers, H. E. (2020) · Journal of Neuroendocrinology · doi:10.1111/jne.12882 · Cited by 18 · see citing works
Self-citationClarke, L., Zyga, O., Pineo-Cavanaugh, P. L., Jeng, M., Fischbein, N. J., Partap, S., Katznelson, L. J., & Parker, K. J. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104770 · Cited by 13 · see citing works
Raymond, J. S., Everett, N. A., Gururajan, A., & Bowen, M. T. (2023) · SLEEP · doi:10.1093/sleep/zsad112 · Cited by 14 · see citing works
Pierce, M. L., French, J. A., & Murray, T. F. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110060 · Cited by 14 · see citing works
Inutsuka, A., Ino, D., & Onaka, T. (2020) · Peptides · doi:10.1016/j.peptides.2020.170456 · Cited by 15 · see citing works
- Authors
- Song, Z., & Albers, H. E.
- Affiliations
- Georgia State University (US)
- Corresponding author
- Albers, H. Elliott
- Venue
- Frontiers in Neuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 51
- Pages
- 14-24
- ISSN
- 0091-3022 (ISSN-L)
- PMC
- PMC5906207
- OpenAlex
- W2767130940
- Semantic Scholar
- 4dbbf2abe3c48e55106808bf85319d02973b36d1
- Cited by
- 244
- References
- 142
- Citations by year
- 2026: 22 · 2025: 32 · 2024: 30 · 2023: 30 · 2022: 25 · 2021: 29 · 2020: 36 · 2019: 18 · 2018: 21 · 2017: 1
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Frontiers in Neuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NSF (IOS-0923301)
- NIH (MH110212, MH109302)
- Topics
- Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- oxytocin, vasopressin, receptor cross-talk, oxytocin receptor, vasopressin receptor, social cognition, social behavior, psychiatric drug development
- MeSH terms
- Animals, Arginine Vasopressin, Mental Disorders, Female, Humans, Male, Oxytocin, Social Behavior, Receptors, Vasopressin, Receptors, Oxytocin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-08.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-08.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review